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5-HT  5-hydroxytryptamine/serotonin 
AC8  adenylyl cyclase 8 
Acb  nucleus accumbens 
ACo  core nucleus of the amygdala 
aCPu   anterior caudate-putamen 
AD  anterodorsal nucleus of the thalamus 
ADAM a  disintegrine and metalloproteinase family of proteases 
ADHD  attention deficit/hyperactivity disorder 
ADo  dorsal region of the amygdala 
APir  amygdalopiriform transition area 
Atf4  activating transcription factor 4 
Atf6  activating transcription factor 6 
AV  anteroventral nucleus of the thalamus 
Bdnf  brain-derived neurotrophic factor 
BL  basolateral nucleus of the amygdala 
BLP  basolateral nucleus of the amygdala, posterior part 
BM  basomedial nucleus of the amygdala 
BMP  basomedial nucleus of the amygdala, posterior part 
BR  blocking reagent 
BSA  bovine serum albumin 
BST  bed nucleus of stria terminalis 
CA  cornu ammonis region of the hippocampus 
CA1  cornu ammonis 1 region of the hippocampus 
cAMP  cyclic adenosine monophosphate 
cDNA  complementary DNA 
CeA  central nucleus of the amygdala 
Chop  C/EBP-homologous protein 
Cisd2  CDGSH Iron Sulphur Domain 2, same as Wfs2 
CoA  cortical nucleus of the amygdala 
CPu  caudate-putamen 
CREB  cAMP responsive element binding protein 
CRH  corticotropin-releasing hormone 
D1  dopamine receptor 1 
D2  dopamine receptor 2 
DAT  dopamine transporter 
DC  dorsal cortex 
Disc1  disrupted in schizophrenia 1 
DLG  dorsal lateral geniculate nucleus 
DM  dorsomedial hypothalamus 
Drd1a  dopamine receptor 1 a 
Drd2  dopamine receptor 2 
Drd3  dopamine receptor 3 
Drd5  dopamine receptor 5 
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DVR  dorsal ventricular ridge 
E  embryonic day 
EA  extended amygdala 
Ect  ectorhinal cortex 
eIF2α  eukaryotic translation initiation factor 2, alpha subunit 
Ent  entorhinal cortex 
Epha2  ephrin type-A receptor 2 
eQTL  expression quantitative trait locus 
ER  endoplasmic reticulum 
ERSE  endoplasmic reticulum stress response element 
Fgfr1  fibroblast growth factor receptor 1 
Fgfr2  fibroblast growth factor receptor 2 
Fgfr3  fibroblast growth factor receptor 3 
GABA  γ-aminobutyric acid 
GABAA γ-aminobutyric acid receptor A 
Gabra1  γ-aminobutyric acid receptor A, α1 subunit 
Gabra2  γ-aminobutyric acid receptor A, α2 subunit 
GAP43  growth associated protein 43 
Glp-1  glucagon-like peptide 1 
GPI  glycosylphosphatidylinositol 
Grp78  78-kDa glucose regulated protein 
Grp94  94-kDa glucose regulated protein 
H+ V-ATPase vacuolar-type H+-ATPase 
Her2  human epidermal growth factor receptor 2 
Her4  human epidermal growth factor receptor 4 
Hprt1  hypoxanthine phosphor-ribosyl-transferase 1 
Hrd1  HMG-CoA reductase degradation 1 homolog 
Hsp70  70 kilodalton heat shock protein 
HSP90  90 kilodalton heat shock protein 
IA  intercalated amygdala 
IgLON  protein family (immunoglobulin Lsamp, Obcam, neurotrimin) 
InP  intrapeduncular nucleus 
IP3  inositol triphosphate 
Ire1  inositol-requiring protein-1 
KO  knockout 
LacZ  β-galactosidase gene 
LacZNeo beta-galactosidase/neomycin fusion gene 
LC  lateral cortex 
LGE  lateral ganglionic eminence 
LHb  lateral habenula 
LP  lateral posterior thalamic nucleus 
Lsamp  limbic system associated membrane protein 
LSt  lateral striatum 
MC  medial cortex 
MeA  medial amygdala 
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MG  medial geniculate nucleus of the thalamus 
MGE  medial ganglionic eminence 
MHb  medial habenula 
MSt  medial striatum 
MYA   million years ago 
Negr1  neuronal growth regulator 1 
NF-κB  nuclear factor kappa B family of transcription factors 
Ntm  neurotrimin 
NTMT 0.1 M NaCl, 0.1 M Tris-HCl pH 9.5, 50 mM MgCl2, 0.001% 
Tween-20 
Opcml  opioid binding protein/cell adhesion molecule like 
P  postnatal day 
Pa  paraventricular nucleus of the hypothalamus 
PB  sodium phosphate buffer 
PBS  phosphate-buffered saline 
pCPu  posterior caudate-putamen 
PCR  polymerase chain reaction 
PERK  protein kinase RNA (PKR)-like ER kinase 
PFA  paraformaldehyde 
PFC  prefrontal cortex 
Pir  piriform cortex 
PRh  perirhinal cortex 
PT  pallial thickening 
qRT-PCR quantitative real-time PCR 
RS  retrosplenial cortex 
Rt  reticular nucleus of the thalamus 
RyR  ryanodine receptor 
SAP  stretch-attend posture 
SC   superior colliculus 
SDS  sodium dodecyl sulphate 
SEM  standard error of the mean 
Serca2  sarco/endoplasmic reticulum calcium transport ATPase 2 
Smurf1 E3  ubiquitin ligase Smad ubiquitination regulatory factor 1 
SNc  substantia nigra, pars compacta 
SNr  substantia nigra, pars reticulata 
SSC  saline sodium citrate buffer 
StAm  strioamygdaloid transition area 
StC  striatal capsule 
StPal  striopallidal area 
Syp1  synaptophysin 
TBST 25 mM Tris-HCl pH 7.5; 140 mM NaCl; 2.7 mM KCl; 0.1% 
Tween-20 
TRH  thyrotropin-releasing hormone 
TTBS 25 mM Tris-HCl pH 7.5; 140 mM NaCl; 2.7 mM KCl; 0.25% 
Triton X-100 
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Tu  olfactory tubercle 
TuSt  striatal part of the olfactory tubercle 
TuStPal striopallidal part of the olfactory tubercle 
UPR  unfolded protein response 
UTR  untranslated region 
VMH  ventromedial hypothalamus 
VPL  ventral posterolateral thalamic nucleus 
VPM  ventral posteromedial thalamic nucleus 
VTA  ventral tegmental area 
Wfs1  Wolfram syndrome 1 
Wfs2  Wolfram syndrome 2, same as Cisd2 
WS  Wolfram syndrome 
Xbp1  X-box binding protein 1 
X-Gal  5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 




Emotions, cognition and memory are all higher-order brain functions with a 
largely shared neural substrate and sensory input. Their operation needs to be 
precisely orchestrated and adjusted through feedback loops in accordance to the 
changing environment. The formation of such feedback loops includes setting 
of the transcription activity of numerous genes and forming and remodelling 
synapses depending on the crosstalk with the environment. As the emotional 
circuits are among those to take the longest to develop and considering the im-
portance of the dialogue between genetics and the environment in sculpting the 
emotional responsiveness of the brain, these neural networks prove the most 
vulnerable to detrimental factors. This is underlined by the existence of a wide 
range of psychiatric disorders targeting the emotional functioning of the brain, 
such as mood, anxiety, impulse control and substance abuse disorders as well as 
psychotic diseases. 
The median age of onset of mental disorders falls into late childhood to early 
adulthood and shows a specificity across the diagnoses (Kessler et al., 2005) 
which indicates a strong developmental factor in the incidence of most 
psychiatric diseases. Adverse life events such as traumatic emotional experience 
or periods of sustained stress can result in the emergence of a genetically 
predisposed mental disease.  
The distant origins of the present thesis are experiments done in early 2000s 
in the Institute of Physiology, University of Tartu. In these experiments, the rats 
were exposed to a cloth immersed in cat odour and gene expression changes 
were measured in the amygdala (Kõks et al., 2002; Kõks et al., 2004). To 
rodents, cat odour indicates the presence of a predator and initiates a fear res-
ponse (File et al., 1993). In the aforementioned experiments, wolframin (Wfs1) 
and the limbic system associated membrane protein (Lsamp) were among those 
genes which had elevated expression levels in the amygdala of the cat odour-
exposed rats (Kõks et al., 2002; Kõks et al., 2004). The amygdala is the central 
regulator of emotional behaviour and its different nuclei are involved in diverse 
aspects of the perception and expression of fear and anxiety (Roozendaal et al., 
2009). At the time of the cat odour experiments, Wfs1 had been identified as the 
causative gene of Wolfram syndrome, a rare condition characterized by the co-
occurrence of diabetes mellitus, diabetes insipidus, sensorineural deafness and 
optic atrophy and often involving psychiatric symptoms; nevertheless, not much 
was known about its function. LSAMP had been identified as a member of the 
immunoglobulin superfamily that takes part in the circuit formation of the 
emotional brain. While the function in the development of the nervous system is 
established for LSAMP, which takes part in neurite outgrowth, axon targeting 
and synaptogenesis (Eagleson et al., 2003; Hashimoto et al., 2009; Keller et al., 
1989; Mann et al., 1998; Pimenta et al., 1995; Zhukareva and Levitt, 1995), 
there are only a few studies pointing to the possible neurodevelopmental role of 
WFS1 (Ghirardello et al., 2014; Hershey et al., 2012). A linkage to mood and 
anxiety disorders, schizophrenia and suicidal behaviour has been established for 
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both WFS1 and LSAMP (Chen et al., 2018; Furlong et al., 1999; Galfalvy et al., 
2013; Koido et al., 2005; Koido et al, 2012; Koido et al., 2014; Must et al., 
2009; Seifuddin et al., 2013; Sokolowski et al., 2016; Swift et al., 1991; Swift et 
al., 1998; Swift and Swift, 2005; Torres et al., 2001; Zalsman et al., 2009). 
Since the roots of neuropsychiatric disorders often lie within brain develop-
ment, the main goal of this thesis is to question during which developmental 
periods Wfs1 and Lsamp are required and investigate the function of these genes 
in the developing and adult brain. First, we studied the initiation pattern of Wfs1 
expression in the mouse brain, viewing it in the setting of neural differentiation 
and developmental endoplasmic reticulum (ER) stress. In the mouse bain, the 
expression of Wfs1 was first initiated at the embryonic day 15.5 (E15.5) and the 
initiation pattern roughly followed the synaptic maturation of brain structures. 
The widespread expression of Wfs1 during the perinatal period was not related 
to the regulation of developmental ER stress. Secondly, the anatomical distri-
bution of Wfs1 expression in the brain was studied in a wider evolutionary con-
text and the relation between WFS1 and D1-type dopamine receptors was in-
vestigated. The expression of Wfs1 was evolutionarily conserved in the striatal 
and subpallial amygdaloid regions but showed greater variation in the pallial 
structures in mammalian, avian and chelonian brains. The expression pattern of 
Wfs1 was notably overlapping with the expression of Drd1a, gene encoding the 
dopamine receptor D1. The ligand binding of D1-type dopamine receptors was 
increased in the hippocampi of Wfs1 knockout mice. Thirdly, we studied the 
activity patterns of the two alternative promoters of the Lsamp gene in the 
developing and adult mouse brain and examined the behavioural outcomes 
related to the expression levels of the alternative transcripts. The two alternative 
promoters showed largely complementary activity patterns: 1a promoter was 
prevailing in the limbic-related structures, while the activity of 1b promoter 
delineated somatosensory pathways. The expression levels of 1a and 1b 
transcripts in different brain regions correlated with characteristics of anxiety-





REVIEW OF LITERATURE 
1. Wfs1 
1.1 Wfs1 gene and Wolfram syndrome 
WFS1, or Wolfram syndrome 1, was named after a syndrome first described by 
Wolfram and Wagener in 1938 (Inoue et al., 1998; Strom et al., 1998; Wolfram 
and Wagener, 1938). Wolfram syndrome (WS) is an autosomal recessive dis-
order characterized by diabetes insipidus, juvenile-onset diabetes mellitus, optic 
atrophy and sensorineural deafness, hence, it is also known under acronym 
DIDMOAD (OMIM #222300). It is a progressive neurodegenerative disease 
and other symptoms often include disturbances in bladder function, ataxia, peri-
pheral neuropathy, epilepsy, brain atrophy, cognitive impairment, and psychiat-
ric manifestations (Chaussenot et al., 2011; Medlej et al., 2004; Rigoli et al., 
2011; Urano 2016). The most common cause of death in WS patients is respira-
tory failure resulting from brainstem atrophy (Barrett et al., 1995). The preva-
lence of WS is 1/770 000 with the carrier frequency of 1/354 in the population 
of the United Kingdom (Barrett et al., 1995). Most of the cases of WS are 
caused by mutations in the WFS1 gene, although there is another causative gene 
called WFS2 or CISD2, mutations of which are related to a much rarer variant 
of WS (Amr et al., 2007; El-Shanti et al., 2000; Inoue et al., 1998; Urano, 
2016). The promoter of WFS1 gene, which is situated in 4p16.1 in the human 
genome (Rigoli et al., 2011), contains a sequence that resembles the endoplas-
mic reticulum (ER) stress response element (ERSE), a regulatory sequence for 
many ER-stress-activated genes (Kakiuchi et al., 2006). In compliance with 
this, the transcription of Wfs1 is upregulated by ER stress (Fonseca et al., 2005; 
Ueda et al., 2005; Yamaguchi et al., 2004). Several ER stress pathway media-
tors can upregulate Wfs1 transcription, including Xbp1, Ire1α, PERK, and 
ATF6β (Fonseca et al., 2005; Kakiuchi et al., 2006; Odisho et al., 2016). Impor-
tantly, a mood stabilizer valproate has been shown to induce the transcription of 
WFS1 in neuronal cells (Kakiuchi et al., 2009). 
A wide range of mutations and polymorphisms has been described in the 
WFS1 gene (Cano et al., 2007; Chaussenot et al., 2011; Cryns et al., 2003b; 
Gomez-Zaera et al., 2001; Hardy et al., 1999; Khanim et al., 2001; Kytövuori et 
al., 2013; van den Ouweland et al., 2003; Qian et al., 2015; Rohayem et al., 
2011; Yu et al., 2010). In addition to WS, some mutations of WFS1 are shown 
to cause nonsyndromic autosomal dominant hearing impairment (Cano et al., 
2007; De Franco et al., 2017; Young et al., 2001) and diabetes (Bonnycastle et 
al., 2013), and recently, three dominant mutations of WFS1 causing co-occur-
rence of neonatal diabetes, sensorineural deafness, congenital cataracts and 
hypotonia were reported (De Franco et al., 2017). Heterozygous carriers of 
WFS1 mutations are at risk to develop diabetes mellitus (Sandhu et al., 2007; 
Wasson and Permutt, 2008) and mental illness (Cryns et al., 2003b; Khanim et 
al., 2001; Koido et al., 2005; Kytövuori et al., 2013; Swift et al., 1998; Swift 
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and Swift, 2005). The most common psychiatric manifestations linked to poly-
morphisms in WFS1 gene include mood disorders and suicidal behaviour (Fur-
long et al., 1999; Koido et al., 2005; Must et al., 2009; Sequeira et al., 2003; 
Zalsman et al., 2009). The pathologies arising from the mutations of WFS1 are 
probably caused by the reduced or diminished level of protein and not by 
accumulation of defective protein (Hofmann et al., 2003; Hofmann and Bauer, 
2006). However, in case of dominant missense mutations, aggregation of 
mutant protein and resulting ER stress seems to lead to the disease symptoms 
(De Franco et al., 2017). 
Wfs1 is expressed in a wide range of tissues, with the highest mRNA levels 
in heart, brain, spinal cord, placenta, intestine, lung and pancreas (Becker et al., 
2008; Inoue et al., 1998; Strom et al., 1998). Antibody staining has revealed that 
the protein expression in the human tissues can vary notably depending on the 
developmental stage: in most tissues, strongest immunostaining of WFS1 is 
observable in late gestation, whereas in adult organism, WFS1 expression is 
reduced or diminished in many cell types (De Falco et al., 2012). Skin, respi-
ratory system, myocardium, spleen and thymus show considerable develop-
mental downregulation, while substantial immunostaining is found in striated 
muscles, smooth muscles of the gastrointestinal system, epithelia of the 
oesophagus and cervix, in liver, endocrine pancreas, thyroid gland, adrenal 
gland, kidney, and testis of adult human (De Falco et al., 2012). In mouse, high 
WFS1 protein levels are reported in heart, brain, pancreas, muscle and liver 
(Hofmann et al., 2003).  
More meticulous studies on Wfs1 expression are performed on the tissues 
and organ systems affected by WS: visual (Kawano et al., 2008; Schmidt-
Kastner et al., 2009; Yamamoto et al., 2006) and auditory system (Cryns et al., 
2003a; Suzuki et al., 2016), brain (Kawano et al., 2009; Luuk et al., 2008; 
Philbrook et al., 2005; Takeda et al., 2001) and pancreas (Ishihara et al., 2004; 
Philbrook et al., 2005). In the visual system, WFS1 protein expression is most 
prominent in retinal ganglion cells (Kawano et al., 2008; Schmidt-Kastner et al., 
2009; Yamamoto et al., 2006). In the inner ear, WFS1 protein is expressed in 
different cell types bordering the scala media of the cochlea, in spiral ganglion, 
and in vestibular hair cells (Cryns et al., 2003a; Suzuki et al., 2016). 
In rodent brain, the most distinct mRNA signal and protein expression is 
present in the CA1 region of the hippocampus, central nucleus of the amygdala, 
parasubiculum, nucleus accumbens, olfactory tubercle, piriform cortex, layer 
II/III of the neocortex, lateral bed nucleus of the stria terminalis, interstitial 
nucleus of the posterior limb of the anterior commissure, and posterior caudate 
putamen (Kawano et al., 2009; Luuk et al., 2008; Takeda et al., 2001). Notably, 
Wfs1 mRNA and/or protein are found in numerous brainstem nuclei and in the 
cerebellum (Kawano et al., 2009; Luuk et al., 2008; Takeda et al., 2001), dys-
function of which might be related to the common symptoms in WS patients, 
e.g. sensorineural deafness, peripheral neuropathy, dysphagia, dysarthria, 
nystagmus, sleep anomalies, gait abnormalities and ataxia (Chaussenot et al., 
2011; Medlej et al., 2004). 
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In this context, it is important to point out the major findings in the brains of 
human WS patients. Numerous studies show neurodegenerative changes that 
encompass brain stem, cerebellum, cerebral cortex, optic nerves, chiasm and 
tracts, lateral geniculate nucleus, hypothalamic paraventricular and supraoptic 
nuclei, and posterior pituitary (Chaussenot et al., 2011; Galluzzi et al., 1999; 
Genis et al., 1997; Hilson et al., 2009; Pakdemirli et al., 2005; Rando et al., 
1992; Shannon et al., 1999). In addition to neurodegenerative processes, WS 
causes neurodevelopmental abnormalities: already in young patients, loss of 
myelination in main white matter tracts, reduced volume of brain stem and 
cerebellar white matter, and thinning of several cortical areas have been found 
(Hershey et al., 2012; Lugar et al., 2016). 
 
 
1.2 The structure of WFS1 protein and its functions 
WFS1 protein comprises of 890 amino acids that make up nine membrane-
spanning segments with long hydrophilic termini (Fig. 1). It assembles into 
tetrameric complexes in the membrane of ER. The N-terminus is glycosylated 
and faces the cytosolic side of the membrane while C-terminus remains in the 
lumen (Hofmann et al., 2003). While it predominantly localizes in the ER 
membrane (Takeda et al., 2001), it has been shown to also reside in the mem-
branes of secretory granules both in pancreatic beta cells and neuronal cells 




Figure 1. A scheme of human WFS1 protein with relative positions of WS-causing 
mutations within the polypeptide chain. Mutations are color-coded according to 
severity: red – complete loss of function; blue – partial loss of function; green – minor 




Several binding partners have been identified for WFS1 protein. The E3 
ubiquitin ligase Smad ubiquitination regulatory factor 1 (SMURF1) interacts 
with WFS1 at the ER and promotes its ubiquitination and proteasomal degrada-
tion (Guo et al., 2011). Interaction between WFS1 and another E3 ubiquitin 
ligase HRD1 helps to stabilize the latter (Fonseca et al., 2010). GRP94, an ER 
resident member of the HSP90 family of molecular chaperones, is another 
binding partner of WFS1, and probably helps to keep WFS1 in an inactive state 
(Kakiuchi et al., 2009). Through its N-terminal domain, WFS1 can bind cal-
modulin in a calcium-dependent manner (Yurimoto et al., 2009). 
In pancreatic beta cells, WFS1 downregulates unfolded protein response 
(UPR) by promoting the degradation of one of the key transcription factors of 
ER stress, ATF6α (Fonseca et al., 2010; see Fig. 2). Thus, in case of deficiency 
in functional WFS1, ER stress pathways are reinforced in pancreatic beta cells, 
which leads to apoptosis and diabetes mellitus (Ishihara et al., 2004; Riggs et 
al., 2005; Yamada et al., 2006). Increased UPR has also been reported in 
WFS1-depleted neuronal cell lines (Gharanei et al., 2013). WFS1 has been 
shown to interact with ß1-subunit of Na+/K+-ATPase and V1A subunit of 
vacuolar-type H+-ATPase (H+ V-ATPase), probably helping to stabilize them 
while maturation in the ER, for the levels of both protein subunits are reduced 
by the depletion of WFS1 in various cell lines (Gharanei et al., 2013; Zatyka et 
al., 2008). Several studies show that lack of functional WFS1 is related to 
alterations in the activity or amount of prohormone convertases and peptide 
hormone processing, but the underlying mechanisms remain to be elaborated 
(Gabreels et al., 1998; Hatanaka et al., 2011; Tein et al., 2015). 
WFS1 has been shown to modulate the filling state of ER Ca2+ store 
(Cagalinec et al., 2016; Hara et al., 2014; Takei et al., 2006) and cytoplasmic 
Ca2+ concentration (Cagalinec et al., 2016; Hara et al., 2014; Lu et al., 2014; 
Osman et al., 2003; Takei et al., 2006; Zatyka et al., 2015). WFS1 modulates 
the activity and turnover rate of sarco/endoplasmic reticulum calcium transport 
ATPase 2 (SERCA2), a protein serving the function of pumping Ca2+ ions from 
cytoplasm to ER (Zatyka et al., 2015). In addition, both ER membrane-resident 
Ca2+ channels – inositol 1,4,5-trisphosphate receptor (IP3R; Cagalinec et al., 
2016) and ryanodine receptor (RyR; Lu et al., 2014) might be involved in 
causing the elevated cytoplasmic Ca2+ concentration and blunted Ca2+ transients 
reported in various models of WFS1 depleted cells (Cagalinec et al., 2016; 
Ishihara et al., 2004; Zatyka et al., 2015). Importantly, elevated cytoplasmic 
Ca2+ concentration is a well-known cause of ER stress (Krebs et al., 2015). 
Thus, in addition to via reduced degradation of ATF6α (Fonseca et al., 2010), 
lack of functional WFS1 contributes to ER stress through the rise of 
cytoplasmic Ca2+ beyond tolerable levels. This, in turn, promotes apoptotic 














































































































































































































































Another important issue related to the ER/cytoplasmic calcium imbalance is the 
resulting disturbance in mitochondrial function, since the energy production in 
mitochondria, mitochondrial dynamics, and mitophagy are highly dependent on 
cellular calcium homeostasis and the ER/mitochondria dialogue through IP3 
receptor (Decuypere et al., 2011). Activation of ER stress pathways, alterations 
in ER-mitochondria association and dysregulation of calcium flow from ER to 
mitochondria have been implicated in the pathology of Parkinson`s disease 
(Bellucci et al., 2011; Calì et al., 2012), Alzheimer`s disease (Area-Gomez et 
al., 2012; Hoozemans et al., 2005), amyotrophic lateral sclerosis (Ito et al., 
2009; Stoica et al., 2014) and Huntington`s disease (Lajoie and Snapp, 2011). In 
this aspect, WS pathology in neurons might share common mechanisms with 
these higher incidence diseases (for a review, see Delprat et al., 2018). Devia-
tions from normal mitochondrial function and increased mitophagy have been 
shown to result from knockdown of WFS1 (Cagalinec et al., 2016) or lack of 
the protein encoded by the other WS-causative gene, Wfs2/Cisd2 (Chen et al., 
2009; Wiley et al., 2013). Due to the resemblance to mitochondrial diseases 
(deafness, optic atrophy and psychiatric findings which indicate neurodegene-
ration caused by the energy deficit), mitochondrial dysfunction has been long 
hypothesized to be the underlying cause of WS symptoms (Barrett et al., 2000; 
Kanki and Klionsky, 2009; Newman, 2005).  
Considerable body of data on the functional importance of Wfs1 has been 
obtained by using genetic invalidation. To date, four Wfs1 knockout (KO) 
mouse models have been generated, two of which harbour the invalidated Wfs1 
gene in all cells (Ishihara et al., 2004; Kõks et al., 2009) and two are conditional 
knockouts lacking Wfs1 in cerebral cortical derivatives (Shrestha et al., 2015) 
and pancreatic β cells (Riggs et al., 2005). Besides the mouse lines, three rat 
lines with disrupted Wfs1 gene have been generated, where exon 5 is targeted 
by deletions (2/3), or an insertion (1/3; Plaas et al., 2017).  
The Wfs1 KO mice generated in our laboratory (Kõks et al., 2009; Luuk et 
al., 2008) exhibit impaired glucose tolerance and higher anxiety in novel and 
stressful situations, which is underlined by higher plasma corticosterone level 
upon stressful events when compared to wild-type (wt) mice, and increased 
sensitivity to the anxiolytic effect of diazepam and ethanol (Luuk et al., 2009; 
Raud et al., 2015). The behavioural deviations of these Wfs1-/- mice probably 
arise from alterations in their GABAergic, dopaminergic and serotonergic sys-
tems (Luuk et al., 2009; Raud et al., 2009; Visnapuu et al., 2013a; Visnapuu et 
al., 2013b). The expression levels of GABAA receptor subunits Gabra1 and 
Gabra2 are reduced in the frontal cortex and temporal lobe of the Wfs1-/- mice; 
similar reduction can be obtained in wt mice by exposing them to elevated plus 
maze (Raud et al., 2009). The dopaminergic transmission is changed both pre- 
and postsynaptically in the Wfs1-/- mice (Luuk et al., 2009; Visnapuu et al., 
2013a). The maximal volume of dopamine output in the striatum is lower com-
pared to wt (Matto et al., 2011), and in compliance with this, the expression of 
dopamine transporter is reduced in the midbrain of Wfs1-/- animals (Visnapuu et 
al., 2013a). The 5-HT transporter is reduced in the pons of the Wfs1-/- mice, 
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accompanied by the lack of increase in serotonin/5-hydroxytryptamine (5-HT) 
metabolites following a stressful challenge, indicating reduced serotonergic trans-
mission in the Wfs1-/- mice generated in our laboratory (Visnapuu et al., 2013b). 
The other Wfs1 KO mouse generated by Ishihara and colleagues (Ishihara et 
al., 2004) develops glucose intolerance similarly to our mouse model (Reimets 
et al., 2016), but otherwise exhibits less severe phenotype, demonstrating only 
subtle deviations from normal behaviour indicating either longer reaction time 
or slightly increased behavioural despair (Kato et al., 2008). Different genetic 
background might contribute to the differences between the two Wfs1 KO 
mouse lines. While the Wfs1-/- mouse studied by Kato and colleagues is bred in 
C57BL/6J background, the Wfs1-/- mouse line generated in our laboratory has 
C57BL/6 × 129S6/SvEvTac mixed background. Compared to C57BL/6, 
129S6/SvEvTac mice are more anxious and display lower exploratory activity 
(Abramov et al., 2008), which might be related to the mutation of Disc1 gene 




2.1 IgLON gene family 
IgLON gene family is a small family of genes encoding neural adhesion mole-
cules, which in turn belongs to the immunoglobulin (Ig) superfamily of cell 
adhesion molecules. Currently, five members of IgLON family are known: 
opioid binding protein/cell adhesion molecule like (Opcml; also known as 
Obcam, Opcm and IgLON1; Schofield et al., 1989), neurotrimin (Ntm; also 
known as HNT, NTRI and IgLON2 in humans, the chick homologue is called 
CEPU-1; Struyk et al., 1995), limbic system-associated membrane protein 
(Lsamp; also known as Lamp and IgLON3; Keller et al., 1989; Levitt, 1984; 
Pimenta et al., 1995), neuronal growth regulator 1 (Negr1; also known as Kilon, 
MGC46680, IgLON4, and neurotractin; Funatsu et al., 1999), and IgLON5 
(from: IgLON family member 5; also known as LOC402665; Gray et al., 2015). 
All IgLON family proteins are extensively glycosylated, contain three immuno-
globulin domains and are tethered to the plasma membrane via a glycosyl-
phosphatidylinositol (GPI) anchor (Itoh et al., 2008). IgLONs can form homo-
dimers and heterodimers, which are called dimeric IgLONs or DIgLONs (Akeel 
et al., 2011; Lodge et al., 2000). Forming homo- or heterophilic dimers is im-
portant for promoting or inhibiting neurite outgrowth (Akeel et al., 2011; Gil et 
al., 2002; Reed et al., 2004). In addition, IgLONs take part in synaptogenesis 
(Hashimoto et al., 2009) and axonal pathfinding and fasciculation (Chen et al., 
2001; Keller et al., 1989; Mann et al., 1998; Schmidt et al., 2014; Singh et al., 
2018). NEGR1, NTM and LSAMP can promote neurite outgrowth as soluble 
factors after being shed from the cell surface by ADAM family metallo-
proteinases (Pischedda and Piccoli, 2016; Sanz et al., 2015; Sanz et al., 2017). 
Several lines of evidence indicate that receptor tyrosine kinases are involved in 
the growth regulating effects of IgLONs. Soluble NEGR1 exerts its neurite 
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growth-promoting functions via the FGFR2 (fibroblast growth factor receptor 2) 
dependent intracellular pathway (Pischedda and Piccoli, 2016), and the inter-
action of OPCML with different receptor tyrosine kinases (including EPHA2, 
FGFR1, FGFR3, HER2, HER4) leads to the internalisation and degradation of 
the latter (McKie et al., 2012). OPCML regulates the growth and proliferation 
of astrocytes (Sugimoto et al., 2010) and acts as a tumour suppressor gene in 
several tissues (Cui et al., 2008; McKie et al., 2012; Reed et al., 2007; Sellar et 
al., 2003). Tumour suppressor role has also been suggested for LSAMP and 
NEGR1 (Barøy et al., 2014; Kim et al., 2014; Ntougkos et al., 2005). Allelic 
variants of NEGR1 have been associated with the reduced myelination of neu-
ronal pathways in the brain (Dennis et al., 2014), depression (Hyde et al., 2016), 
and obesity (Willer et al., 2008). Elevated level of NEGR1 has been associated 
with psychiatric disorders including major depression, bipolar disorder and 
schizophrenia (Maccarrone et al., 2013), and deletion of NEGR1 causes 
language disabilities and learning deficiency (Genovese et al., 2015; Tassano et 
al., 2015; Veerappa et al., 2013). NTM is involved in axonal fasciculation and 
synaptogenesis in the central nervous system and promoting Schwann cell 
migration in the peripheral nervous system (Chen et al., 2001; Yu et al., 2012). 
NTM has been associated with intelligence (Pan et al., 2011) and with its close 
neighbour OPCML belongs to the risk locus for Alzheimer`s disease, ADHD, 
depression, schizophrenia and autism at 11q25 (Baye et al., 2008; Blacker et al., 
2003; Liu et al., 2007; Magri et al., 2010; Ogdie et al., 2003; Schol-Gelok et al., 
2010; Vorstman et al., 2006; Ye et al., 2012). Association to schizophrenia has 
been suggested to all IgLON genes besides the most recently discovered 
IgLON5 (Chen et al., 2018; Koido et al., 2014; O’Donovan et al., 2008; 
Panichareon et al., 2012; Ripke et al., 2014; Wang et al., 2010). Increased 
mRNA expression levels of NEGR1 and NTM 1b as well LSAMP and NEGR1 
protein have been found in the dorsolateral prefrontal cortex of the patients of 
schizophrenia (Behan et al., 2009; Karis et al., 2018). IgLON5 was brought 
under wider attention after identification as a protein targeted by autoantibodies 
in case of a tauopathic sleep disorder involving parasomnia and obstructive 
sleep apnoea and often accompanied by ataxia, dysphagia and hypoventilation 
(Gelpi et al., 2016; Sabater et al., 2014). 
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2.2 The structure of Lsamp gene and the function of LSAMP protein 
LSAMP gene (also known as Lamp or IgLON3) is located at 3q13.31 in the 
human genome and it is composed of 11 exons distributed over 2.2 megabases 
(Mb; Pimenta and Levitt, 2004). LSAMP gene contains two alternative first 
exons with separate promoters, which encode distinct signal peptides, but yield 
an identical mature protein (see Fig. 3; Pimenta and Levitt, 2004). Additional 
variation becomes from alternative splicing near the 3´ end of the mRNA, 
which results in including or omitting an insertion of 23 amino acids (exons 7 
and 8; Pimenta and Levitt, 2004). Lsamp gene, including its two-promoter struc-
ture, is highly conserved among vertebrates. The cDNA nucleotide sequence 
identity is 94% and amino acid sequence identity is 99% between rat and human 
(Pimenta et al., 1996a) and 91% between rat and chicken (Brümmendorf et al., 
1997). Mature LSAMP is a 64–68 kDa protein (Pimenta et al., 1995). It contains 
three immunoglobulin domains and a GPI anchor in its C-terminal region, which 
binds it to the extracellular side of the plasma membrane of neurons of the limbic 
system (Levitt, 1984; Pimenta et al., 1995; Zacco et al., 1990).  
Polymorphisms of LSAMP gene are associated with schizophrenia (Chen et 
al., 2018; Koido et al., 2014), depression (Koido et al., 2012), panic disorder 
(Koido et al., 2012), and suicide (Galfalvy et al., 2013). It is worth noting that 
besides LSAMP, 3q13.31 chromosomal locus contains several genes implicated 
in the neural development and psychiatric disease, including DRD3, ZBTB20, 
and GAP43 (Blennow et al., 1999; Chen et al., 2018; Davies et al., 2014; 
Lowther et al., 2014; Nunokawa et al., 2010), which, residing in proximity to 
each other, could share common regulatory mechanisms. According to Fromer 
et al. (2016), the location of the expression quantitative trait locus (eQTL, i.e. 
site that influences the level of gene expression) (rs74731643) that is in-
fluencing the expression level of LSAMP gene is more than 2 Mb upstream of 
LSAMP gene (see also Karis et al., 2018). This provides evidence that the 
regulatory areas of LSAMP can span over a wider genomic area and LSAMP can 
be coregulated with other genes in the neighbourhood, contributing to the 
genetic risk for neurodevelopmental/neuropsychiatric conditions. 
LSAMP specifically participates in regulating the formation of limbic cir-
cuits by promoting cell adhesion, synapse formation, neurite outgrowth and 
axon targeting in limbic structures (Eagleson et al., 2003; Hashimoto et al., 
2009; Keller et al., 1989; Pimenta et al., 1995; Schmidt et al., 2014; Zukhareva 
and Levitt, 1995). While attracting axons from limbic-associated thalamic 
nuclei, it can mediate repulsion for non-limbic thalamocortical axons (Mann et 
al., 1998). The inhibition might be mediated by heterophilic binding with other 
IgLON family members, for the coexpression of LSAMP and NTM inhibits 
neurite outgrowth in several models (Akeel et al., 2011; Gil et al., 2002). Like-
wise, coexpression of LSAMP and NTM reduces the number of synapses on 
hippocampal neurons (Hashimoto et al., 2009). In dorsal root ganglions, shed-
ding of LSAMP from the cell surface by metalloproteinase ADAM10 relieves 




































































































































































































































































































































Besides having role in the development and functioning of the nervous system, 
LSAMP also serves as a tumour suppressor. Reduced level of LSAMP resulting 
from deletions or methylation of the promoter region has been shown in patients 
of osteosarcoma (Barøy et al., 2014; Kresse et al., 2009; Pasic et al., 2010; Yen 
et al., 2009), acute myeloid leukaemia (Kühn et al., 2012), prostate cancer 
(Petrovics et al., 2015), clear cell renal sarcoma (Chen et al., 2003) and epithe-
lial ovarian cancer (Ntougkos et al., 2005). One study associates a case of acute 
myeloid leukaemia with increased expression level of LSAMP (Coccaro et al., 
2015). Polymorphism in LSAMP gene yielding lower transcription level has 
been associated with coronary artery disease (Dungan et al., 2016; Wang et al., 
2008).      
LSAMP was first described in the rat brain as a protein with specific expres-
sion in the limbic system – the network of cortical structures, subcortical nuclei 
and pathways involved in processing of emotional information in the brain 
(Horton and Levitt, 1988; Levitt, 1984). In the foetal rat brain, the mRNA of 
Lsamp is first detected at E13-E14 in the developing striatum, preoptic area, 
amygdala, diencephalon, midbrain and hindbrain (Pimenta et al., 1996b), and 
LSAMP protein is first found at E15 in the fibres coursing from diencephalon to 
the cortex through the internal capsule (Horton and Levitt, 1988). The in situ 
hybridization studies in the developing and adult rat brain confirmed the pro-
minent expression of Lsamp in limbic structures, such as hippocampus, 
extended amygdala, ventral and dorsal striatum, and preoptic and hypothalamic 
areas, but additionally, Lsamp mRNA was found in several brain regions related 
to somatosensory and motor function, e.g. somatosensory cortical regions and 
thalamic nuclei, midbrain and hindbrain (Pimenta et al., 1996b; Reinoso et al., 
1996). In addition to rat, the expression of LSAMP protein has been studied in 
the brain of cat (Chesselet et al., 1991), cynomolgus monkey (Macaca fasci-
cularis; Côté et al., 1995; Côté et al., 1996), human (Prensa et al., 1999; Prensa 
et al., 2003; Uroz et al., 2004) and pigeon (Yamamoto and Reiner, 2005; Yama-
moto et al., 2005), confirming its presence principally in the limbic structures in 
different evolutionary lineages. During the development, LSAMP is present 
along the growing axons, cell somata and both pre- and postsynaptically in the 
forming synapses, whereas in adult brain, the immunoreactivity only remains in 
the dendrites and cell body (Horton and Levitt, 1988; Zacco et al., 1990). In the 
chick embryo, Lsamp protein expression is found in the retinotectal pathway, 
axon-dense regions of the spinal cord, ventral root of the spinal nerve, and 




AIMS OF THE STUDY 
The overall aim of the present thesis is to give insight into the mechanisms by 
which two genes, Wfs1 and Lsamp, are involved in the regulation of the 
development and functioning of the neural circuits underlying behaviour. 
Describing the neuroanatomical distribution and elucidating the roles of WFS1 
and LSAMP in the brain development helps to better understand their functions 
related to the susceptibility to psychiatric diseases. The precise aims are as 
follows: 
1.  To describe the initiation pattern of Wfs1 expression in relation to major 
developmental events in the mouse brain.  
2.  To study the role of WFS1 in the regulation of the developmental ER stress 
in the mouse brain.  
3.  To study the evolutionary conservation of the expression of Wfs1 in amniote 
brain. 
4.  To explore the relation between Wfs1 and dopaminergic system and target 
the role of WFS1 in D1-like receptor dependent signalling. 
5.  To describe the spatial activity pattern of the two alternative promoters of 
the Lsamp gene from the developmental aspect and to investigate their 
significance in anxiety-related and social behaviour in mice.  
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MATERIALS AND METHODS 
1. Ref I 
The expression of WFS1 had earlier been studied in our laboratory by Luuk and 
colleagues in the adult mouse brain by immunohistochemistry and X-gal 
staining of Wfs1-β-galactosidase knockin mouse brains (Luuk et al., 2008). 
Nothing was known about the initiation and embryonic expression of Wfs1, 
therefore, we decided to focus on these events, taking advantage of the non-
radioactive in situ RNA hybridization method to see the earliest events and 
localize the cell bodies that express Wfs1. We also added several postnatal 
stages in our study, to provide a continuous series of coronal sections helping to 
understand the general changes in the expression pattern in each brain structure 
and to complement the in situ hybridization study published by Kawano et al. in 
2009. Because one of the established functions of WFS1 is regulating the ER 
stress, we hypothesized that WFS1 might take part in the regulation of the 
developmental ER stress in neurons. To test our hypothesis, we applied in situ 
RNA hybridization of Grp78 and Grp94 genes and real-time quantitative 
polymerase chain reaction (qRT-PCR) on ER stress markers Grp78, Grp94 and 
CHOP in wt and Wfs1-/- mouse brains.  
 
 
2. Ref II  
In the second paper, we took an evolutionary approach to study the function of 
WFS1 in the tetrapodean brain, using mouse, domestic chick/common quail and 
red-eared slider turtle as representatives of the different phylogenetic lineages. 
Regarding the distribution of WFS1 in the dopaminoceptive brain regions and the 
reported deviations in the dopaminergic system of Wfs1 KO mice (Luuk et al., 
2009; Visnapuu et al., 2013a), we took under closer investigation the relation 
between WFS1 and D1-type dopamine receptors. For this, we used in situ RNA 
hybridization, immunohistochemistry and radioactive ligand binding assay. 
 
 
3. Ref III 
Because Lsamp gene contains two conserved promoters that yield an mRNA 
with the different first exons, but identical protein, we aimed to study the func-
tional significance of the dual promoter structure. First, we studied the pattern 
of the promoter activity in the developing and adult mouse brain by radioactive 
and non-radioactive in situ RNA hybridization and by X-gal staining of Lsamp-
β-galactosidase knockin mouse brains. Secondly, since Lsamp KO mice as well 
as psychiatric patients show deviations in fear and anxiety related and social 
behaviour, we studied the correlation between the Lsamp promoter activity and 
measures of trait anxiety and social behaviour. Additionally, we measured the 
expression of Lsamp 1a and 1b transcripts upon acute fear response. In the first 
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part of behavioural testing, we used a battery of elevated plus-maze test, loco-
motor activity test, and social interaction test. Following the last test, the 
expression of Lsamp transcripts was measured in the ventral striatum, hippo-
campus and temporal lobe by qRT-PCR. In the second part of behavioural 
testing, fear conditioning was applied to study the effect of acute fear on the 
expression of Lsamp transcripts in the hippocampus and temporal lobe. The 
expressions of Lsamp transcripts and immediate early gene c-Fos were mea-




All the mice (Mus musculus) were housed under standard laboratory conditions 
(12-h light/dark cycle with free access to food and water) at the Laboratory 
Animal Centre of the Institute of Biomedicine and Translational Medicine, 
University of Tartu (accreditation number KL1210), and were killed by cervical 
dislocation or decapitation. In case of transcardial perfusion, animals were 
deeply anaesthetized by intraperitoneal injection of ketamine and xylazine (100 
mg/kg and 10 mg/kg, respectively; paper II) or mixture of Hypnorm® (yielding 
0.3 mg/kg of fentanyl citrate and 10.7 mg/kg fluanisone; Janssen Animal 
Health, Buckinghamshire, UK) and Dormicum® (yielding 1.3 mg/kg of mida-
zolam; Roche, Mannheim, Germany; paper III, immunohistochemistry) or 
pentobarbital (paper III, radioactive in situ hybridization). Two lines of knock-
out mice were used in the present studies; the description of the generation of 
the knockout mouse lines is provided below. In paper I, wt C57BL/6 mice were 
used for in situ hybridization studies and wt and Wfs1-/- [(129S6/SvEvTac 
(Taconic) × C57BL/6) × (129S6/SvEvTac × C57BL/6)] mice were used in 
quantitative real-time PCR experiments. In paper II, wt C57BL/6 mice were 
used for in situ hybridization and immunohistochemistry and male wt and Wfs1-/- 
[(129S6/SvEvTac × C57BL/6) × (129S6/SvEvTac × C57BL/6)] were used for 
radioligand binding experiments. In paper III, C57BL/6 mice were used for in 
situ hybridization experiments, Lsamp-/- [(129S6/SvEvTac × C57BL/6) × 
(129S6/SvEvTac × C57BL/6)] mice were used for X-gal staining and male 
C57BL/6 mice were used for behavioural studies. 
In paper II, in addition to mice, we used chicken (Gallus gallus domesticus), 
quails (Coturnix coturnix) and red-eared slider turtles (Trachemys scripta). 
Chicken were obtained from commercial poultry farm Tallegg and from the 
Science Centre AHHAA in Tartu, Estonia in cooperation with Tallegg. Quails 
were obtained from commercial quail farming company Järveotsa Vutifarm 
OÜ. Turtles were purchased commercially from the Kliebert Turtle and Alli-
gator Farm (Hammond, Louisiana). Chicken and quails were killed by decapi-
tation. Turtles were anaesthetized by intramuscular ketamine and xylazine 
injection (90 mg/kg and 6 mg/kg, respectively) combined with hypothermia 
induced by keeping the animal in ice before decapitation. The approximate 
number and other data of all the animals used for the preparation of papers I, II 
























































































































































































































































































































































































































































































































































































































4.1 Wfs1 knockout mice 
The knockout strategy for creating Wfs1
-/-
 mouse line is published by Luuk et 
al., 2008 and Kõks et al., 2009. In brief, by using targeted homologous re-
combination, amino acids 360–890 of WFS1 protein were replaced by and an 
in-frame NLSLacZNeo cassette, resulting in fusion protein consisting of WFS1 
residues 1–360 and β-galactosidase. Wfs1
-/-
 mice (Wfs1-β-galactosidase knockin 
mice) with mixed genetic background [(129S6/SvEvTac × C57BL/6) × (129S6/ 
SvEvTac × C57BL/6)] were used for quantitative real-time PCR experiments in 
Ref I and radioligand binding experiments in Ref II. Mixed genetic background 
was used to avoid robust background effects on gene expression. 
 
4.2. Lsamp knockout mice 
The knockout strategy for creating Lsamp
-/-
 mouse line is described in detail in 
Innos et al., 2011. In brief, exon 1b of Lsamp gene was replaced by a 
NLSLacZNeo cassette by targeted homologous recombination. Lsamp
-/-
 
(Lsamp-β-galactosidase knockin) [(129S6/SvEvTac × C57BL/6) × (129S6/ 
SvEvTac × C57BL/6)] mice were used for X-gal staining in Ref III.  
 
 
5. Non-radioactive in situ RNA hybridization  
(papers I, II and III) 
The used mouse Wfs1 riboprobe template sequence is available at: GenBank ref 
|NM_011716.2| Range 1: 2210–2686. In case of Lsamp, the cDNA fragment 
specific for 1a promoter (400 bp) consisted of 1a specific 5´UTR, exon 1a and 
exon 1a´. Universal Lsamp probe (567 bp) was transcribed from a cDNA frag-
ment consisting of exons 2–6. cDNA fragment sequences used as templates for 
Dig-labelled riboprobes for other genes were obtained using the following pri-
mers (containing restriction sites of HindIII and XhoI for Syp1, SalI and NotI 
for all others): 
Mouse Syp1 For  CCCA AGCT Tgggggtcagttccgggtggt 
Mouse Syp1 Rev  CCGC TCGA Gcttcacatcggacaggcctt 
Mouse Grp78 For  TTTG TCGA  Ctgcagcaggacatcaagttc 
Mouse Grp78 Rev TTTGC GGCC  GCaatccttgcttgatgctga 
Mouse Grp94 For  TTTG TCGA  Catggcacagtggaagaggac 
Mouse Grp94 Rev TTTGC GGCC  GCgtttcctcttgggtcagcaa 
Mouse Drd1a For TTTGC GGCC  GCctctgctgcttttggacag 
Mouse Drd1a Rev TTTG TCGA  Ctaggggcagagcattggtag 
Mouse Drd5 For  TTTGC GGCC  GCgagaactgtgactccagcct 
Mouse Drd5 Rev  TTTG TCGA  Cgacatgtgatcgaaaggccc 
Chick Drd1a For  TTTGC GGCC  GCatgacttggaacgacaccact  
Chick Drd1a Rev    TTTG TCGA  Cagttgctctcaggttgctgg  
Chick Wfs1 For  TTTGC GGCC  GCgacagaagaggcatcacttctgagaa  
Chick Wfs1 Rev  TTTG TCGA Cctcatgtagcttgtcactgtgaagaa 
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The brains of mice, chicken and turtles were dissected and fixed at 4°C in 4% 
paraformaldehyde (PFA) in 0.1 M phosphate-buffered saline, pH 7.4 (PBS) for 
1–5 days depending on the size of the brain. Subsequently, the brains were 
immersed overnight at 4°C in the cryoprotectant consisting of 20% sucrose in 
2%PFA/PBS and kept frozen in -80°C until further processing. in situ RNA 
hybridization was carried out on free-floating 40 μm cryosections using 
digoxigenin-UTP (Roche) labelled sense and antisense RNA probes. At first, 
the sections were rinsed twice in PBS containing 0.25% Triton X-100 (PBST) 
and once in 5X SSC (pH 5). Next, the sections were prehybridized for 1 hour at 
65°C in prehybridization mixture containing 50% formamide, 5X SSC (pH 5), 
2% blocking reagent (BR; Roche), following overnight hybridization in the 
same conditions with hybridization mixture containing 50% formamide, 5X 
SSC, 1% BR and 1 µg/ml probe (heated at 80°C for 5 min and cooled on ice 
prior to adding to the hybridization mixture). To control the specificity of RNA 
probe binding, some sections were incubated with the sense probe. After the 
hybridization, the sections were washed for 30 min at 65°C in solution 
containing 50% formamide, 5X SSC and 1% SDS, following 2 x 30 min at 
60°C in 50% formamide, 2X SSC. Next, the sections were rinsed three times in 
TBST (25 mM Tris-HCl pH 7.5; 140 mM NaCl; 2.7 mM KCl; 0.1% Tween20) 
and blocked against non-specific antibody binding for 1h in TBST containing 
2% BR. Then, the sections were incubated overnight at 4°C in 1% BR/TBST 
with 1:2000 anti-digoxigenin antibody conjugated to alkaline phosphatase 
(Roche). On the third day, the sections were washed three times in TBST, fol-
lowing two washes in NTMT (0.1 M NaCl, 0.1 M Tris-HCl pH 9.5, 50 mM 
MgCl2, 0.001% Tween20). Then, the sections were transferred into the alkaline 
phosphatase substrate BM Purple AP Substrate (Roche) and when sufficient 
staining had appeared, the reaction was terminated by transferring the sections 
into PBS. All washing and incubation steps were carried out under rocking. The 
stained sections were transferred onto slides in 0.5% gelatine, air dried and 
mounted with Pertex (Histolab).  
In case of turtle, we used chick Wfs1 and Drd1a probes and the hybridization 
was carried out at 60°C and post-hybridization washes at 60°C and 57°C. Using 
NCBI BLAST, we analysed the sequence identity between the chick cDNA 
sequences corresponding to the probes and the transcriptome of Trachemys 
scripta (accessible from Kaplinsky et al., 2013). The sequence identity was 88% 
(682 nucleotides of 773) in case of Drd1a and 89% (786 nucleotides of 887) in 
case of Wfs1. 
In case of E13.5 mouse brains in paper III, whole-mount in situ hybridi-
zation was carried out. The dissected brains and/or embryos were fixed in 4% 
PFA/PBS at 4°C overnight, then dehydrated in increasing concentrations of 
methanol in 0.1% Tween-20/PBS (25%, 50%, 75%, 2 x 100%) and rehydrated 
with the same concentrations of methanol in 0.1% Tween-20/PBS in reversed 
order, following washing with 0.1% Tween-20/PBS. To degrade the proteins, 
the specimens were treated with 10 μg/ml proteinase K (Fermentas) in PBS for 
10 min and the reaction was terminated by 2 mg/ml glycine in 0.1% Tween-
31 
20/PBS. Then, following washing with 0.1% Tween-20/PBS, the specimens 
were refixated with 4% PFA/0.2% glutaraldehyde/PBS for 20 min. After 
washing from the fixative, the specimens were put into prehybridization mix 
containing 50% formamide and 5 x SSC (pH 5), where they were stored at -
20°C until further processing. The prehybridization was carried out in 50% 
formamide/5 x SSC/1% SDS/1% BR at 70 °C for 1.5h under rocking and 
hybridization with 1 μg/ml heat-activated (see above) RNA probe was carried 
out overnight in the same conditions. The following steps were the same as 
described before for the 40 μm sections, with minor modifications. The first 
washing step after the hybridization with 50% formamide, 5X SSC and 1% SDS 
was carried out 2 x 30 min and after the incubation with anti-digoxigenin 
antibody (Roche), the specimens were washed with TBST for 6 times and left 
washing in TBST at 4 °C until the next day. The next day, the specimens were 
washed three times in NTMT and kept in BM Purple AP Substrate (Roche) until 
desired staining developed. For cutting 50-μm vibratome sections, the stained 
specimens were inserted into 1 ml of 0.5% gelatine/30% bovine serum albumin 
(BSA)/20% sucrose/PBS, wherein 140 μl of 25% glutaraldehyde was added 
immediately before insertion and incubated for 10 min. The sections were 
mounted on glass slides with 70% glycerol. 
 
 
6. Radioactive in situ RNA hybridization 
Mouse Lsamp sequence accessible from UCSC Genome Browser, genome. 
ucsc.edu (Accession No. uc007zfr.1) was used as a template sequence for 33P-
dUTP labelled antisense 40′mer DNA oligonucleotide probes:  
Mouse Lsamp1a   5′-accccagcacccagacgctgtgcagccagtaggtcctcat-3′ 
Mouse Lsamp1b  5′-gaagaaggcagagcagtctcagtaggaccagcggcaactg-3′ 
Mouse LsampUNI  5′-agagcatggcgcttctccagctcaacccgagggtccagag-3′  
In situ hybridization on free-floating sections was carried out as described in 
Hundahl et al. 2010. 
 
 
7. Immunohistochemistry (papers II and III) 
For non-fluorescent immunohistochemistry, the mice were transcardially per-
fused with 2% PFA/PBS under ketamine and xylazine anaesthesia. The brains 
were dissected and kept in 2% PFA/PBS for 1 h and cryoprotected overnight in 
20% sucrose in 1% PFA/PBS at 4°C. Until further processing, the brains were 
kept frozen at -80°C. Immunohistochemical protein detection was carried out on 
free-floating 40 μm cryosections. First, the sections were washed two times in 
Tris-buffered saline containing 0.25% Triton X-100 (TTBS) and treated with 
0.3% H2O2 in ddH2O for 15 min to quench the endogenous peroxidase activity, 
following three washes in TTBS. Next, unspecific antibody binding was 
blocked with 5% horse serum (Vector Laboratories) in TTBS for 1h. The 
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incubation with primary antibody (diluted in 2% horse serum in TTBS) was 
carried out at room temperature for 1h, then at 4°C overnight. The antibodies 
were: rabbit polyclonal WFS1 (the same as in Luuk et al., 2008, diluted 
1:1000), rabbit polyclonal D1 (#ADR-001, Alomone Labs, diluted 1:1000), and 
rabbit polyclonal D5 (#ADR-005, Alomone Labs, diluted 1:1000). The next 
day, the sections were washed three times in TTBS and incubated with the 
biotinylated anti-rabbit antibody (Vector Laboratories, dilution 1:400) in 1% 
horse serum in TTBS for 1h. The antibody binding was detected using the Vec-
tastain Elite ABC Kit (Vector Laboratories) according to the protocol provided 
by the manufacturer. Briefly, the biotinylated secondary antibody was bound to 
streptavidin and horseradish peroxidase reaction with diaminobenzidine (DAB; 
Vector Laboratories) was used to visualize immunoreactivity. The stained 
sections were transferred onto slides in 0.5% gelatine, air dried and mounted 
with Pertex (Histolab). All washing steps and longer incubations were carried 
out under rocking. Specificity of the immunohistochemistry was determined by 
incubations without the primary antibody. 
For fluorescent immunohistochemistry, quail and turtle brains were fixed for 
4 h in 4% PFA/PBS, washed with PBS following impregnation with 30% 
sucrose in ddH2O at 4°C, and were frozen and stored at -80°C. The brains were 
cut into 40 μm freely floating coronal cryosections. The sections were perme-
abilized with 0.3% TritonX-100/PBS over 30 min and blocked against non-
specific antibody binding with 5% donkey serum (Jackson ImmunoResearch 
Laboratories Inc.) /1% BSA (Sigma)/PBS over 1 h. Next, the incubation with 
WFS1 antibody (1:400 in 1% BSA /0.1% Tween-20/PBS) was carried out at 
room temperature for 1h, then at 4°C overnight. After three washing steps with 
0.3% TritonX-100/PBS, the sections were incubated in FITC conjugated goat 
anti-rabbit secondary antibody solution (1:1000, Jackson ImmunoResearch 
Laboratories Inc.) in 0.1% Tween-20/1% BSA/PBS for 2 h. Nuclei were co-
unterstained with DAPI (4,6-diamidino-2-phenylindole, Sigma Aldrich) 1: 2000 
dilution in secondary antibody buffer. Sections were further washed in PBS and 
mounted in Fluoromount (Sigma Aldrich) mounting medium. All washing steps 
and longer incubations were carried out under rocking. Specificity of the 
immunohistochemistry was determined by incubations without the WFS1 
primary antibody. 
To visualize neuronal nuclei, immunohistochemistry with NeuN antibody 
(Millipore, clone A60, cat. no. MAB377) was performed in Ref III. Briefly, 5% 
normal goat serum (Dako) was used for blocking, NeuN antibody was diluted to 
1:1000 in 0.25% TritonX-100/PBS with 2% goat serum, and goat anti-mouse 
IgG antibody coupled to Alexa Fluor 488 fluorescent dye (cat. no. A11001, 
Molecular Probes, diluted 1:500 in 0.25% TritonX-100/PBS with 2% goat 
serum) was used as the secondary antibody. After staining, the sections were 
transferred to gelatinized glass slides and mounted in a 1:1 mix of glycerol and 
PBS. 
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8. X-gal staining (paper III) 
To demonstrate the activity of Lsamp 1b promoter, the detection of β-galacto-
sidase activity was performed by X-gal staining. The adult Lsamp-β-galacto-
sidase knockin mice were transcardially perfused under combined fentanyl, 
fluanisone and midazolam anaesthesia with 2% PFA in 0.1 M sodium 
phosphate buffer (PB), pH 7.4. The brains were dissected, cut into halves and 
kept overnight in 20% sucrose/1% PFA in PB, frozen, and cut into 100 μm free-
floating sections. The sections were stained overnight in 5 mM K3Fe(CN)6,  
5 mM K4Fe(CN)6, 1 mg/ml X-gal, 0.125% Triton X-100 in PB at room tempe-
rature. After staining, the sections were incubated in 2% PFA solution in PB, 
transferred to glass slides and mounted with Pertex (Histolab). For X-gal 
staining, E13.5 (embryonic day 13.5) and E15.5 brains and/or embryos were 
fixed in 4% PFA/PBS at 4 °C for 30 min. For cutting 50-μm vibratome sections, 
the stained (E13.5 and E15.5) specimens were inserted into 1 ml of 0.5% 
gelatine/30% BSA/20% sucrose/PBS, with 140 μl of 25% glutaraldehyde as 
described above. The sections were mounted on glass slides with 70% glycerol. 
 
 
9. Quantitative real-time PCR (papers I and III) 
The mice were decapitated, and brains were dissected out. Whole forebrains 
(paper I) or temporal lobes, hippocampi and ventral striata (paper III) were 
frozen in liquid nitrogen. Taqman system (Applied Biosystems) was employed 
for measuring the expression levels of Grp78, Grp94 (paper I), Lsamp 1a and 
1b transcripts and c-Fos (paper III). The detailed description of the method used 
for measuring the expression levels of Grp78 and Grp94 is provided in 
Visnapuu et al., 2013b. For the description of the method used for measuring 
the expression levels of Lsamp transcripts and c-Fos, see Ref III. The expres-
sion analysis of Chop was performed using SYBR Green system as in Örd et al. 
(2012). In all cases Hprt1 was used as the housekeeper gene, as it has con-
sistently shown stable results as a reference gene for brain tissues in our 
laboratory. 
The primer sequences and assays used for real-time PCR experiments were 
the following: 
Mouse Grp94 (Hsp90B1) Taqman assay Mm00441927_m1 
Mouse Grp78 For 5’- cataaaccccgatgaggctgta -3’   
Mouse Grp78 Rev 5’-cacctgtatcctgatcaccagaga-3’ 
Mouse Grp78 probe 5’-VIC-tggtgccgctgtccaggctg-MGB-3’ 
Mouse CHOP For 5’-ctgcctttcaccttggagac-3’ 
Mouse CHOP Rev 5’-cgtttcctggggatgagata-3’ 
Mouse Hprt1 For 5’-gcagtacagccccaaaatgg-3’ 
Mouse Hprt1 Rev 5’- aacaaagtctggcctgtatccaa-3’ 
Mouse Hprt1 probe 5’-VIC-aagcttgctggtgaaaaggacctctcg-TAMRA-3’ 
Mouse Lsamp probe     5’-FAM-aaccgaggcacggacaac-MGB-3’ 
Mouse c-Fos                  Taqman assay Mm00487425_m1 
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In paper I, the impact of genotype and mouse age on the expression levels of 
Grp94, Grp78, and Chop was estimated with Type III ANOVA realized in the 
SAS procedure GLM (SAS Inst Inc, 2008). The terms of the underlying GLM 
model were the main effects of gene and genotype, their interaction and the 
mouse stage subjected to gene and genotype. Comparison of the effects of 
selected factor combinations was estimated with the Estimate option provided 
by the GLM procedure. For each of the 24 combinations of gene × stage × 
genotype, seven animals were measured. 
In paper III, all data were analysed using Statistica version 8.0 (StatSoft, 
Inc.). As the behavioural scores were not normally distributed, Spearman’s 
rank-order method was used for the calculation of correlation coefficients. In 
the fear conditioning study, one-way ANOVA (conditioning type as grouping 
variable) was performed. Tukey HSD post hoc analysis was used when applic-
able after statistically significant ANOVA. 
 
 
10. Radioligand [3H]SCH23390 binding assay (paper II) 
To better understand the relation between Wfs1 and D1-type dopamine recep-
tors, we used radioligand binding assay to determine the amount of D1-type 
dopamine receptors in wt and Wfs1-/- mice. The detailed description of the 
radioligand binding assay is provided in paper II. Briefly, the mice were 
decapitated, the hippocampi were rapidly dissected, frozen in liquid nitrogen 
and stored at -80°C until further processing. The hippocampi were homogenized 
by ultrasound sonication, and membrane preparations were made by centri-
fugation at 30 000 g. In radioligand binding curve experiments, the hippo-
campal membranes of 6 mice from corresponding group (wt or Wfs1-/-) were 
pooled and used at concentration of 20 mg tissue/ml. The membranes were in-
cubated with different dilutions (0.06–8.2 nM) of a D1-like receptor radioligand 
[3H]SCH23390 (81.9 Ci/mmol, PerkinElmer) in the absence (for total binding) or 
in the presence (for nonspecific binding) of 10 μM (+)-butaclamole (Sigma-
Aldrich), a dopaminergic antagonist. Samples were incubated for 60 min at 25°C 
and the reactions were stopped by rapid filtration through thick GF/B glass fibre 
filtermats using FilterMate Harvester (both from PerkinElmer). Solid scintillant 
MeltiLexTM B/HS was then impregnated into the filter by using MeltiLexTM 
Heatsealer. The filter-bound radioactivity was counted using a Wallac MicroBeta 
TriLux 1450 LSC Luminescence Counter (all from PerkinElmer). The total 
concentrations of radioligand dilutions were determined in vials with 3 ml of 
liquid scintillation cocktail OptiPhase HiSafe (PerkinElmer). 
The number of binding sites of D1-like receptors in wt and Wfs1 KO mice 
hippocampi was estimated by determination of specific binding of 4 nM 
[3H]SCH23390 as described above. The tissue concentration in these experi-
ments was 6.7 mg/ml. 
All the data were analysed using GraphPad Prism 5.0 (GraphPad Software 
Inc). Data are presented as mean ± SEM of at least three independent experi-
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ments carried out at least in duplicates. Statistically significant differences were 




11. Behavioural experiments (paper III) 
All behavioural studies were done with 2 months old male C57BL/6 mice. Male 
mice were used to avoid the possible impact of the oestrous cycle on the 
experimental results. In the first part of the behavioural studies, we investigated 
the correlations between general behavioural profile and the expression of 
Lsamp transcripts in the hippocampus, temporal lobe and ventral striatum. All 
mice (n = 15) were subjected to a battery of three behavioural tests: elevated 
plus-maze test (day 0), locomotor activity test (day 5), and social interaction test 
(day 10). The motility box test was carried out as described in Innos et al. 2013. 
Four behavioural parameters were recorded: (1) time spent moving (move, s); 
(2) distance travelled (distance, m); (3) time spent in the centre (time centre, s); 
and (4) time spent in the corners (time corner, s). The plus-maze experiment 
was performed as described in Philips et al. (2010) and eight behavioural 
parameters were recorded: (1) the number of closed arm entries; (2) the number 
of open arm entries; (3) the ratio between open and closed arm entries; (4) the 
latency to enter open arm (latency, s); (5) time spent on open arms; (6) the 
number of protected head-dips; (7) the number of unprotected head-dips; and 
(8) the number of stretch-attend postures (SAPs). The social interaction test was 
carried out as described previously (Innos et al. 2012), briefly: 14 mice were 
matched into 7 pairs of two unfamiliar mice according to the bodyweight. (1) 
The time spent sniffing the partner’s anogenital area (anogenital sniffing, s) and 
(2) the time spent sniffing other body regions (sniffing other body parts, s) were 
recorded separately. These two measures were also summarized for (3) the time 
of total social sniffing for each animal (time of social sniffing, s). The animals 
were decapitated 10 days after the last experiment and the ventral striatum 
(including nucleus accumbens and olfactory tuberculi), hippocampus and tem-
poral lobe (including temporal cortex and amygdala) were dissected from the 
brains. 
In the second part of the behavioural studies, we investigated the influence 
of acute fear reaction on the expressional activity of the Lsamp gene. In order to 
induce acute fear reaction, fear conditioning was carried out by means of a 
computer-controlled Multi Conditioning System (TSE). Sixteen mice were 
divided into three groups: “naïve” (n = 5); “pre-conditioning” (n = 5) and 
“conditioned fear” (n = 6). The mice in “pre-conditioning” and “conditioned 
fear” groups underwent fear conditioning, which was performed in a dimly 
illuminated (15 lx) acrylic cage (30 × 30 × 30 cm) with stainless steel rod floor. 
Between subjects the cages were cleaned with isopropanol. On the first day 
after 150-s acclimation period animals received six trials with the following 
stimuli: 15 s tone (12 kHz; 70 dB) and bright light (pulsing at 200 ms) were 
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terminated by a 2-s electric shock (0.6 mA) during which the light was constant. 
Inter-trial interval was 120 s (±50%). After the last trial the animals were 
returned to their home cages. On the second day, animals in the “conditioned 
fear” group were placed into the conditioning cages and exposed to similar 
stimuli without an electric shock for about 45 min (20 trials). The animals were 
killed immediately afterwards. “Naïve” and “Pre-conditioning” groups received 
no treatment on the second day. The hippocampus and temporal lobe (including 
the temporal cortex and the lateral, basolateral, central and medial nuclei of the 
amygdala) were dissected from the brains. 
The data were analysed using Statistica version 8.0 (StatSoft, Inc.). As the 
behavioural scores were not normally distributed, Spearman’s rank-order 
method was used for the calculation of correlation coefficients. In the fear con-
ditioning study, one-way ANOVA (conditioning type as grouping variable) was 
performed. Tukey HSD post hoc analysis was used when applicable after 
statistically significant ANOVA. Data are presented as mean ± SEM. 
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RESULTS AND DISCUSSION 
1. Wfs1 expression is initiated at the time of intense 
synaptogenesis and achieves mature pattern after 
puberty (Ref I, Ref II) 
Neuroimaging studies in young WS patients have revealed defects in axon 
myelination and brain growth (Ghirardello et al., 2014; Hershey et al., 2012; 
Lugar et al., 2016), suggesting a role in the brain development for WFS1. 
Therefore, we addressed the initiation of Wfs1 expression in the developing 
brain, by studying it in parallel with the marker of synaptic activity, synapto-
physin (Syp1). 
First, when comparing the initiation pattern of Wfs1 in two evolutionarily 
distant lineages, mouse and domestic chick, it appears that Wfs1 is first ex-
pressed in the phylogenetically older striatal and amygdaloid regions at the time 
when most neurons have migrated to their destination and begin to make 
contacts to build up the neural network. This finding suggests that Wfs1 is not 
involved in neurogenesis, neuronal migration or neurite outgrowth, but more 
likely in later neurodevelopmental processes. 
In mouse brain, the mRNA of Wfs1 could be first detected at E15.5 in the 
developing striatum and central and medial amygdala (CeA and MeA, respec-
tively; see Fig. 4E-H, same as Ref I, Fig. 1E-H). This falls in the time window 
of the beginning of synaptic functioning in the subcortical regions of the brain, 
as shown by the expression of Syp1 (Fig. 4A-D, same as Ref I, Fig. 1A-D).  
In the domestic chick brain, the expression of Wfs1 started between  
E10 – E13 (Ref II, S2 Fig. A-B). Like in the mouse, the first structures that ex-
pressed Wfs1 in the chick brain were striatal and subpallial amygdaloid regions. 
Another similarity between the two species was that the most widespread 
expression of Wfs1 occurred during the development, around the time of birth in 
the mouse (at P2; Ref I, Fig. 2A-D) and hatching in the chick (at E20; Ref II, S2 
Fig. C-D). The early expression pattern of Wfs1 in mouse and chick brain 
suggests that it follows the ontogenetic development of the brain structures, 
appearing first in the phylogenetically older regions and later in the phylo-
genetically newer pallial structures. It is possible that the expression of Wfs1 is 
activated by the synaptic activation of neurons or by the high embryonic 
expression of ER stress pathway mediators, such as spliced XBP1 (Hayashi et 
al., 2007; Kakiuchi et al., 2006).  
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Figure 4. The initiation and developmental dynamics of Wfs1 expression in the mouse 
brain. mRNA in situ hybridization on coronal brain sections. For comparison, Syp1 
expression as a marker of synaptic maturation is depicted in A-D. The expression of 
Wfs1 is initiated at E15.5 (E-H), achieves widespread expression in most of the fore-
brain and diencephalon by birth (I-L) and shows widespread downregulation and 
specific upregulation by adulthood (M-P). Abbreviations: Acb-nucleus accumbens, 
aCPu-anterior caudate-putamen, Au-auditory cortex, BL-basolateral nucleus of the 
amygdala, BLP-basolateral amygdala, posterior part, BM-basomedial nucleus of the 
amygdala, BST-bed nucleus of stria terminalis, CA-cornu ammonis, CA1-cornu 
ammonis 1, CA3-cornu ammonis 3, CeA-central nucleus of the amygdala, Cg-cingulate 
cortex, CoA-cortical nucleus of the amygdala, CP-cortical plate, DG-dentate gyrus, 
DM-dorsomedial hypothalamus, Ect-ectorhinal cortex, Ent-entorhinal cortex, GP-
globus pallidus, h-hippocampus, Hy-hypothalamus, Ins-insular cortex, IPAC-interstitial 
nucleus of the posterior limb of the anterior commissure, La-lateral nucleus of the 




























































































































dorsal part, LSI-lateral septal nucleus, intermediate part, LSV, lateral septal nucleus, 
ventral part, M-motor cortex, mCPu-medial caudate-putamen, MeA-medial nucleus of 
the amygdala, MS-medial septal nucleus, pCPu-posterior caudate-putamen, Pa-para-
ventricular nucleus of the hypothalamus, PF-parafascicular nucleus of the thalamus, Pir-
piriform cortex, PMV-ventral premammillary nucleus, PRh-perirhinal cortex, PV-para-
ventricular nucleus of the thalamus, RS-retrosplenial cortex, Rt-reticular thalamic 
nucleus, S-somatosensory cortex, Su-subiculum, Th-thalamus, Tu-olfactory tubercle, 
Vi-visual cortex, VM-ventromedial hypothalamus. Scale bar 1 mm. Adapted from Ref I, 
Fig. 1 and 2. 
 
 
The shaping out of the expression pattern of Wfs1 progressed gradually, in-
volving numerous temporary events. In mouse, there were several brain regions 
that lost the expression of Wfs1 entirely or almost entirely by adulthood. The 
early postnatal widespread expression in the diencephalon (Ref I, Fig. 1O-P, 
Fig. 2C-D) remained only weakly in the reticular nucleus of the thalamus (Rt) 
and paraventricular, dorsomedial and ventromedial hypothalamic nuclei (Ref I, 
Fig. 2N-O). In the septum, the expression of Wfs1 became restricted to the 
dorsal part of the lateral septal nucleus (LSD) in the adult brain (Ref I, compare 
Fig. 2A vs Fig. 2M). In the anterior caudate-putamen (aCPu), Wfs1 expression 
persisted only in the ventral and medial tiers (Ref I, compare Fig. 1M-N, Fig. 
2A-B vs Fig. 2M-N). In the caudal aspects of the amygdala, including MeA, 
posterior basomedial (BMP) and posterior basolateral (BLP) nuclei, the re-
markably strong perinatal signal was downregulated to weak level by the adult-
hood (Ref I, Fig. 1K-L, P, Fig. 2D, O-P).  
Since the formation of the neural network underlying the emotional beha-
viour, including fear and anxiety, largely depends on environmental feedback, 
the shaping out of these circuits takes place late after birth (Bouwmeester et al., 
2002; Casey et al., 2017; Cressman et al., 2010; Wolterink et al., 2001). The 
developmental dynamics of Wfs1 in the mouse MeA, BMP and BLP could 
reflect the prolonged maturation of the fear-associated circuits. MeA receives 
prominent vomeronasal input and its function is involved in sensing the pre-
sence of a predator and generating a predator-induced fear response (Dielenberg 
et al., 2001; Martinez et al., 2011; Scalia and Winans, 1975). The activation of 
the basolateral amygdala promotes the expression of fear and is required for 
storing and modulating fear memories (Maren et al., 1996; Sierra-Mercado et 
al., 2011). Neural activity in the basomedial amygdala suppresses fear beha-
viour (Adhikari et al., 2015). The posterior division of basomedial amygdala is 
particularly interesting in the context of Wfs1 expression, as it mostly projects to 
other Wfs1-expressing regions like pre- and infralimbic cortices, ecto- and 
perirhinal cortices, parts of lateral, central, medial and cortical amygdala, 
nucleus accumbens, bed nucleus of stria terminalis, ventromedial hypothalamus 
and posterior caudate-putamen (Petrovich et al., 1996). This probably indicates 
the requirement of WFS1 during the formation of certain interconnected fear-
related neural pathways.  
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The developmental dynamics of the Wfs1 expression pattern in the mouse 
septum correlates well with the maturation of the septal serotonergic, dopa-
minergic and enkephalinergic afferent connections and hippocampal input, 
which advances in medial to lateral manner and accomplishes after the second 
postnatal week (Sheehan et al., 2004). Likewise, in the chick, the maturation of 
Wfs1 expression in the septum was prolonged, as it was present only in the 
medial septal nucleus of the adult bird, but not in any of the developmental 
stages considered (Ref I S3 Fig. A, C). 
The developmentally transient expression of Wfs1 in the anterior CPu of the 
mouse suggests that in the dorsal striatum, Wfs1 expression is initiated during 
the time of synaptic activation and plays a role specifically during the develop-
ment. CPu is a large structure primarily involved in the generation of voluntary 
movements, but it also participates in associative and motivational aspects of 
behaviour. As a matter of fact, the dorsomedial striatum is connected to the 
cortical and thalamic regions attributed to limbic functions, and takes part in 
goal-directed behaviour, versus habitual behaviour controlled by the dorsola-
teral striatum (Burton et al., 2015; Voorn et al., 2004). Consistent with this, the 
expression of Wfs1 persists near the medial margin of the aCPu, reassuring its 
involvement in the emotional circuits of the brain. The other subregion of the 
CPu retaining the Wfs1 expression in adulthood is the posterior CPu (pCPu), 
which is the site for the convergence of auditory and dopaminergic stimulation 
(Arnauld et al., 1996). 
Of the cortical structures of the mouse, the expression of Wfs1 first appeared 
at E18.5 in the regions that are phylogenetically older and showed established 
Syp1 signal by E17.5 (see Ref I, Fig. 3C-D), namely in the piriform cortex (Pir), 
insular cortex, ecto-, ento- and perirhinal cortices (Ect, Ent and PRh, respec-
tively), cortical amygdala (CoA) and hippocampus (Ref I, Fig. 1I-L). In these 
structures, the expression gained strength during the subsequent days and 
became prominently strong by P20 (Ref I, Fig. 1M-P, Fig. 2A-L). The expres-
sion in the hippocampus spread throughout the CA region and the developing 
dentate gyrus after birth (Ref I, Fig. 1N-P, Fig. 2C-D, F-H) and became 
restricted to the CA1 only after P7 (Ref I, Fig. 2K-L, Fig. 5M). The first 
entorhinal axons arborize in the CA region of the hippocampus at E17 (Supèr 
and Soriano, 1994), just before the beginning of Wfs1 expression. Dentate 
gyrus, which is one of the main input gateways to the hippocampus in adult-
hood, is shaped out during the postnatal development (Altman and Bayer, 1990; 
Leuner and Gould, 2010; see also Ref I, Fig. 3C-H). Therefore, we propose that 
the initiation of Wfs1 expression in the hippocampus is caused by the early 
synaptic activity and the refinement of the expression pattern occurs after the 
main synaptic input through the dentate gyrus becomes functional. 
In the neocortex, which is the last structure to become anatomically and 
functionally mature, the Wfs1 expression took long to initiate. In accordance 
with the inside-out order of the development of the cerebral cortex (Angevine 
and Sidman, 1961; Rakic, 1974), the deeper layers showed specific pattern of 
Syp1 expression first (Ref I, Fig. 4B, D, F). The expression of Wfs1 also 
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appeared first in the deeper layers and later in more superficial layers. Layer 
II/III, the Wfs1-expressing layer in the adult brain, started expressing Wfs1 as 
late as at P4, beginning with auditory, motor, cingulate and retrosplenial cortical 
fields (Ref I, Fig. 2E-H). Layer V, which is the source of long subcortical 
projections, showed transient expression between birth and adulthood (Ref I, 
Fig. 1M-O, Fig. 2A-P, Fig. 4C, E, G, I, K, M). Likewise, layer VIb/subplate 
showed temporary expression of Wfs1 between P0 and P4 (Ref I, Fig. 1M, Fig. 
2A-C, E, Fig. 4E). Majority of the neurons in layer VIb are short-lived and they 
fulfil specific role during the development, establishing the first pioneering 
axons that guide the thalamocortical axons to their cortical target (Molnár et al., 
1998a; Molnár et al., 1998b; Price et al., 1997). When reaching the developing 
cortex, the growing thalamocortical axons usually arrest for several days and 
make synaptic contacts with the neurons of layer VIb (Higashi et al., 2005; 
Molnár et al., 1998a; Molnár et al., 1998b). It is worth pointing out, that layer 
VIb resembles the reticular nucleus of the thalamus (Rt) in many ways: also, Rt 
loses its volume by adulthood and serves as a resting and rearranging compart-
ment for the growing corticothalamic axons (Jacobs et al., 2007; Molnár and 
Cordery, 1999; Montiel et al., 2011). We first observed the expression of Wfs1 
in the Rt at E18.5 (Ref I, Fig. 1K), which is the time when the growing 
corticothalamic axons leave Rt and start to invade the dorsal thalamus (Jacobs 
et al., 2007). All in all, the pattern of the initiation of Wfs1 in the neocortex and 
Rt favours the hypothesis that the expression of Wfs1 is initiated by the 
beginning of synaptic activity and (largely) transient expression in layers V and 
VIb and in Rt might refer to the temporarily increased synaptic activity during 
the time of Wfs1 expression. In general, our findings in the mouse were well in 
accordance with the study published by Kawano and co-workers in 2008, which 
focussed on the postnatal changes in the expression pattern of Wfs1. An over-
view of the developmental expression pattern of Wfs1 in the mouse brain is in 
Supplementary Table 2a in Ref I. 
Like in the mouse, there were some regions in the chick brain where the 
expression of Wfs1 was downregulated by adulthood. Most notably, the relati-
vely widespread expression in the pallial amygdala of the embryonic chick 
became only faintly detectable in the dorsal region of the amygdala (ADo) and 
amygdalopiriform transition area (APir) in the adult chick (Ref II, compare S2 
Fig. C-D vs Fig. 5H). This suggests the common developmental dynamics of 
Wfs1 expression in the posterior pallial amygdala in mammalian and avian 




2. Lack of functional WFS1 does not result in  
the alteration of ER stress markers in the developing 
mouse brain (Ref I) 
ER plays essential role in the post-translational modification, folding and traf-
ficking of secretory and membrane-bound proteins, phospholipid biosynthesis 
and calcium storage. Perturbed functioning of the ER results in ER stress, which 
is manifested by the accumulation of unfolded proteins. The protein folding 
status in the ER is sensed by the luminal domains of three ER membrane-
resident proteins: inositol-requiring protein-1 (Ire1), activating transcription 
factor-6 (Atf6) and protein kinase RNA (PKR)-like ER kinase (PERK). To 
alleviate the ER stress, these proteins initiate the intracellular signalling path-
ways collectively known as unfolded protein response (UPR) or ER stress 
response. UPR involves the general attenuation of protein synthesis, while up-
regulating the production of chaperones and degrading misfolded proteins. It 
also mediates apoptosis under severe ER stress (for a review, see Ron and 
Walter, 2007). While ER stress can result from numerous environmental 
challenges and pathological conditions (Zhao and Ackerman, 2006), activation 
of UPR signalling pathways is also essential during the normal development in 
different cell types (Rutkowski and Hedge, 2010). Most notably these include 
the cells possessing immense secretory capacity, such as antibody-producing B 
lymphocytes (Gass et al., 2002; Reimold et al., 2001; Zhang et al., 2005) and 
exocrine cells of the pancreas and salivary glands (Lee et al., 2005), but also 
cardiomyocytes (Masaki et al., 1999), hepatocytes (Reimold et al., 2000), osteo-
blasts (Pereira et al., 2004; Saito et al., 2011), dendritic cells (Iwakoshi et al., 
2007), and placental cells (Iwawaki et al., 2009). 
Physiological ER stress also occurs during the development of the nervous 
system. ER stress pathways are activated in the brain during the embryonic 
(Zhang et al., 2007) and postnatal development (Hayashi et al., 2007) and UPR 
signalling is required for neuronal differentiation (Cho et al., 2009) and neurite 
growth (Favero et al., 2013). The correct timing of attenuation of the develop-
mental UPR is crucial for proper neural development, as shown in the mouse 
cerebral cortex (Laguesse et al., 2015).  
The most well-known function of WFS1 is alleviating ER stress response/ 
UPR, which has been extensively studied in the pancreas (Fonseca et al., 2005; 
Fonseca et al., 2010; Shang et al., 2014; Ueda et al., 2005; Yamada et al., 2006). 
There is also evidence that depletion of WFS1 in neuronal cells upregulates ER 
stress response pathways and apoptosis (Cagalinec et al., 2016; Gharanei et al., 
2013).  
Regarding the remarkably widespread expression of Wfs1 at the perinatal 
period, it is tempting to hypothesize that WFS1 is needed in many neurons 
specifically during the beginning of synaptic activity, which might be related to 
the developmental ER stress. Birth or hatching drastically exposes the animal to 
large number of new sensory stimuli that need to be processed in the brain. This 
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requires the acquisition of the full capacity of the protein synthesis machinery, 
which is challenging to the neurons. Widespread expression of Wfs1 seen in the 
brain around the time of birth/hatching might reflect its role in coping with the 
strenuous intracellular environment. We addressed this question by measuring 
the levels of UPR genes in the brains of wild-type (wt) and Wfs1-/- mice during 
the perinatal period between E17.5 and P4. We confirmed the developmental 
downregulation of ER stress response genes Grp78, Grp94 and CHOP (Fig. 5; 
Ref I, Fig. 5a, b, S Table 4). Each was highly expressed in the embryonic brain 
and underwent abrupt decrease by the time of birth. Interestingly, the expression 
level of Grp78 temporarily rose again during the following postnatal days 
before obtaining its low adult level (Fig. 5; Ref I, Fig. 5a, b). We did not 
observe differences in the expression dynamics of Grp78, Grp94 and CHOP 
between Wfs1-/- and wild-type (wt) mice, suggesting that the lack of Wfs1 does 
not alter the activity of UPR pathways in the developing brain between E17.5 
and P4 (Fig. 5; Ref I, Fig. 5b, S Table 4). There are still some limitations to this 
result, for we did not investigate the expression of ER stress response related 
genes in specific brain structures, but in the whole forebrain. It might still be the 
case that in some structures where WFS1 is expressed, it could take part in 
regulating the ER stress response. Secondly, there are several other mediators in 
the ER stress pathways. Whereas the upregulation of Grp-s is general outcome 
of all ER stress pathways, upregulation of CHOP reflects a severe stress and 
results from the activation of PERK-eIF2α-ATF4 pathway (Kadowaki and 
Nishitoh, 2013). Also, different regions in the brain are vulnerable to excess ER 
stress at different times during the development. Wang and co-workers (2015) 
showed that the injection of ER stress inducer tunicamycin upregulated UPR 
pathways in the developing brain and caused caspase-3 activation in the layer II 
of parietal cortex, CA region of the hippocampus and external granule cell layer 
of the cerebellum at P4. At P12 the activation of caspase-3 had shifted to the 
dentate gyrus of the hippocampus, deep cerebellar nuclei, and pons, and no 
caspase-3 activation was detected in mice injected at P25 (Wang et al., 2015). 
Indeed, the lack of WFS1 contributes to the activation of IRE1-dependent ER 
stress pathway in the temporal lobe upon exposure to mild stress in adult mice 





Figure 5. The expression of Grp78 and Grp94 in the brains of wt and Wfs1 knockout 
(ko) mice during the perinatal period as revealed by quantitative real-time PCR analysis. 
Estimated expression levels with 95% confidence limits (indicated as rectangles); 




Taken together, we can conclude that the reason why the expression of Wfs1 is 
initiated in a much wider variety of brain regions during the perinatal 
development is probably not the requirement for downregulating ER stress 
response. Instead, it might be necessary for the modelling of neural network. 
WFS1 has been shown to interact with the E3 ubiquitin ligases SMURF1 and 
HRD1, which are involved in the neurodevelopmental processes (Bryan et al., 
2005; Kawada et al., 2014). In particular, WFS1 stabilizes the ER stress-
inducible HRD1 (Fonseca et al., 2010) and is degraded by ER stress-sensitive 
SMURF1 (Guo et al., 2011). In the medial prefrontal cortex of adult mice, the 
restraint stress-induced production of WNT7A and neurotrophin3 (NTF3), two 
proteins involved in neural development and synaptic remodelling, is altered by 
the deletion of Wfs1 (Shrestha et al., 2015). Thus, the widespread perinatal 
expression of Wfs1 might be needed for the regulation of the developmental 
processes dependent on Wnt family proteins, neurotrophins or ubiquitin ligases 
(Ascano et al., 2012; Hall et al., 2000; Upadhyay et al., 2017). 
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3. The expression of Wfs1 is conserved in subpallial 
regions, but more varied across lineages in the pallial 
derivatives of the amniote forebrain (Ref I, Ref II) 
We decided to address the evolutionary conservation of the expression of Wfs1 
by comparatively studying it in rodent (mouse), avian (domestic chick) and 
chelonian (red-eared slider turtle) lineage. The divergence between the mam-
malian and sauropsid (including birds and reptiles) lineages occurred approxi-
mately 317 million years ago (MYA) and the split between birds and turtles 
occurred about 257 MYA (Shen et al., 2011). Studying the conservation of gene 
expression can bring us closer to understanding the function of our gene of 
interest, also, it might indicate how the functions of the homologous brain 
structures have diverged during the evolution. In addition, the developmental 
pattern of gene activation can provide valuable information about the ancestral 
situation and formation of brain structures and circuits. 
As also shown by other authors (Kawano et al., 2009; Luuk et al., 2008), the 
highest Wfs1 expressing regions in mouse were the CA1 region of the hippo-
campus, central extended amygdala, Pir, pCPu, and ventral striatum (Ref I, Fig. 
2M-P). In the chick brain, the strongest expression was seen in the medial 
striatum (MSt), other regions with considerably strong signal were the caudal 
part of lateral striatum (LSt), striopallidal area (StPal), strioamygdaloid transi-
tion area (StAm), extended amygdala (EA), striatal part of the olfactory tubercle 
(TuSt), and striopallidal part of the olfactory tubercle (TuStPal; Ref II, Fig. 5A-
C, G). In the red-eared slider turtle, Wfs1 was expressed in striatal regions 
(including striatum (St), nucleus accumbens (Acb), olfactory tubercle (Tu)), 
striatoamygdalar area (StA), dorsal ventricular ridge (DVR), pallial thickening 
(PT), dorsal cortex (DC) and partially in the medial cortex (MC; Ref II, Fig. 
7A-D). 
Altogether, in mouse, chick and turtle, striatal structures and the subpallial 
nuclei of the amygdala were expressing Wfs1 while the pallidal regions lacked 
the expression. This suggests that the expression in the subpallium shares a 
common developmental origin. The projection neurons of the striatal structures, 
including the dorsal and ventral striatum, as well as the central and intercalated 
nuclei of the amygdala are derived from the lateral ganglionic eminence (LGE) 
in the developing brain, while the medial ganglionic eminence (MGE) gives rise 
to the globus pallidus and ventral pallidum and the striatal and cortical inter-
neurons (Deacon et al., 1994; Marin et al., 2000; Olsson et al., 1998). As the 
CPu, Acb, Tu and CeA of the mouse (Ref I, Fig. 2M-O, Ref II, Fig. 1A, G), 
MSt, LSt, intrapeduncular nucleus (InP), Acb, TuSt, TuStPal, StPal, StAm and 
EA of the chick (Ref II, Fig. 5A-C, G) and St, Acb, Tu and StA of the turtle 
(Ref II, Fig. 7A-C) were all expressing Wfs1, while globus pallidus and ventral 
pallidal territories were devoid of expression, a conclusion can be derived that 
the expression of Wfs1 might be common for the LGE derivatives across the 
tetrapods. 
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The medial to lateral gradient of Wfs1 expression across the avian striatum 
further supports the proposal that Wfs1 functions in emotional and motivational 
rather than purely somatomotor circuits in the striatum (see chapter 1 of Results 
and Discussion). The medial division of the avian MSt receives pallial input 
from the hippocampus and olfactory bulb (Veenman et al., 1995) and thalamic 
projections from the midline and intralaminar thalamic nuclei associated with 
viscerolimbic functions (Veenman et al., 1997), while the dopaminergic input 
preferentially arises from the ventral tegmental area (Mezey and Csillag, 2002). 
More lateral MSt receives pallial input from regions involved in somatosensory, 
visual, auditory and motor function (Veenman et al., 1995) and dopaminergic 
input from the substantia nigra (Mezey and Csillag, 2002). Also, LSt receives 
its input mainly from somatic pallial and thalamic regions (Veenman et al., 
1995; Veenman et al., 1997) and might be comparable to the mammalian 
dorsolateral CPu (Kuenzel et al., 2011). Thus, Wfs1 might have a conserved 
role in the viscerolimbic functions of the striatum. 
An interesting finding was that the mammalian intercalated amygdala (IA) 
and its putative avian homologue, striatal capsule (StC) were both expressing 
Wfs1 (Ref II, Fig. 2A, C, E), supporting the homology proposed by Abellán and 
Medina, 2009, and suggesting that Wfs1 has a conserved function in this 
structure, probably related to the regulation of fear behaviour. The intercalated 
cell masses in the amygdala are providing feedforward inhibitory control over 
the basolateral and central nuclei, thus suppressing the fear behaviour (Ehrlich 
et al., 2009; Paré et al., 2003). Considering the behavioural outcomes of the 
ablation of Wfs1 (Luuk et al., 2009), it would be reasonable to guess that the 
function of the intercalated amygdala might be affected in Wfs1-/- mice. As the 
intercalated cells are GABA-ergic, and changes in the GABA-ergic system have 
been shown to underscore the anxiety-related behaviour in Wfs1-/- mice (Raud et 
al., 2009; Raud et al., 2015), the role of WFS1 in the intercalated amygdala 
would deserve a more in-depth study.  
In the bed nucleus of the stria terminalis (BST), the expression of Wfs1 was 
present in both mouse and chick (Ref I, Fig. 1J, N, Fig. 2B, J, N; Ref II, Fig. 
5C, G, S1Fig. B, G), but showed developmental downregulation in the latter 
(compare Ref II, Fig. 5G vs Ref II, S1Fig. G). BST belongs to the extended 
amygdala system, together with the central and medial nuclei of the amygdala. 
While the central nucleus of the amygdala mainly derives from the LGE, then 
BST and medial amygdala contain cell groups derived from the MGE, LGE, 
anterior peduncular area, commissural preoptic area, as well as ventral pallial 
and extratelencephalic progenitor domains (García-López et al., 2008). 
Similarly to mammals, the heterogenic developmental origin of the BST and 
medial amygdala has been established in the avian and reptilian brain (Abellán 
and Medina, 2009; Moreno et al., 2010; Puelles et al., 2000; Vicario et al., 
2014). We did not distinguish the BST in the turtle brain, but the comparison 
with the detailed study of Moreno and colleagues, 2010 suggests that the BST is 
situated in the Wfs1-expressing region on the septal side of the ventral horn of 
the lateral ventricle, adjacent to the Acb (Ref II, Fig. 7A, B). In addition, the 
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Wfs1-expressing region designated as the circumventricular organ striopallidal 
organ (SPO) in our study (Ref II, Fig. 5B, C, S1Fig. A, B, F, G), based on 
Puelles et al., 2007, might in fact represent the dorsal and dorsomedial divisions 
of the lateral BST (Abellán and Medina, 2009; Vicario et al., 2014), but further 
study with region-specific markers would be needed to clarify this. 
Despite the closer evolutionary relatedness, the expression pattern of Wfs1 in 
the pallial brain regions was considerably different between turtle and chick. 
While the expression of Wfs1 was largely lacking in the chick pallium, it was 
relatively widespread in the pallial structures of turtle and mouse. Notably, the 
derivatives of the dorsal and medial pallium almost entirely lacked the 
expression in the chick brain but showed conspicuously strong expression in 
mouse and turtle. In both, mouse and turtle, Wfs1 was strongly expressed in the 
hippocampal homologue, in the CA1 region of the hippocampus in mouse and 
in the MC in the turtle (Ref I, Fig. 2 O-P; Ref II, Fig. 7A-C). In the turtle MC, 
Wfs1 was expressed in the region proximal to the DC (Ref II, Fig. 7A-C). In the 
hippocampal formation of the chick, only subset of cells in the parahippocampal 
area were expressing Wfs1 (Ref II, Fig. 5I). Since the avian parahippocampal 
area and reptilian dorsomedial cortex both correspond to the regions in mam-
malian hippocampus proper (Manns and Eichenbaum, 2009), the expression of 
Wfs1 specifically in these regions might reflect the ancestral state in stem 
amniotes. 
The distribution of the expression of Wfs1 in the derivatives of the dorsal 
pallium, i.e. neocortex in the mouse, hyperpallium in the chick and dorsal 
cortex in the turtle, suggested independent gain in mouse and turtle, or 
alternatively, loss in the avian lineage. In mouse, Wfs1 was expressed in the 
layer II/III of all neocortical fields except the retrosplenial cortex (RS), 
nevertheless, during the development, RS too showed the expression of Wfs1 
(Ref I, Fig. 2C, G, M-P). In the chick hyperpallium, there was no Wfs1 
expression at any developmental stage. In turtle, DC was the strongest Wfs1 
expression site, which probably reflects its importance in this brain structure.  
We propose that the strong expression of Wfs1 in the DC of the red-eared 
sliding turtle is a consequence of functional specification rather than indicator 
of evolutionary conservation. The cortical neurons of freshwater turtles are 
remarkably resistant to hypoxia and excitotoxicity (Wilson and Kriegestein, 
1991; Doll et al., 1991). The resistance to neuronal damage includes reducing 
neuronal energy expenditure, downregulating excitatory amino acid release 
while increasing GABA release, inhibiting pro-apoptotic and activating pro-
survival pathways (Kesaraju et al., 2009; Lutz and Milton, 2004; Nayak et al., 
2016). In addition, the brains of freshwater turtles express innately higher levels 
of Hsp70 family heat shock proteins, stress-responsive transcription factor NF-
κB, and harbour enhanced capacity to fight reactive oxygen species (Lutz and 
Milton, 2004; Prentice et al., 2004; Rice et al., 1995; Willmore and Storey, 
1997). Interestingly, Grp94, a molecular partner of Wfs1, is among the genes 
that are strongly induced in the brain of red-eared slider turtle in response to 
anoxia (Kesaraju et al., 2009). Several studies show that ER stress and hypoxia 
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response are interconnected and UPR pathways can be activated in response to 
hypoxia (Koumenis et al., 2002; Pereira et al., 2014; Romero-Ramirez et al., 
2004; see Wouters and Koritzinsky, 2008 for review). Based on this evidence, 
and the role of Wfs1 in regulating ER stress response (Fonseca et al., 2005; 
Fonseca et al., 2010; Yamada et al., 2006), we hypothesize that the strong 
expression in the DC of the red-eared slider turtle is related to the hypoxia 
tolerance of this species. Therefore, it would be interesting to compare the ob-
tained results with the expression of Wfs1 in a non-hypoxia resistant chelonian 
species. 
The lateral pallial derivative pallial thickening showed strong Wfs1 
expression in the turtle (Ref II, Fig. 7A-C), its putative mammalian homologues 
claustrum and endopiriform nucleus (Bruce, 2009) did not express Wfs1 at any 
developmental stage. Nevertheless, Puelles et al., 2016, suggest that the 
mammalian homologue for the pallial thickening could be the insular cortex, 
which showed strong expression of Wfs1 in the mouse (Ref I Fig. 2M-N). The 
lateral cortex (LC) of the turtle did not express Wfs1, but its putative 
mammalian homologue Pir is one of the strongest Wfs1-positive regions in the 
mouse brain (Ref II Fig. 7A-C, Fig. 1A, G; Bruce, 2009). However, the 
homology between many pallial derivatives is still disputable. Martínez-García 
et al., 2009 favour considering the reptilian lateral cortex homologous to 
mammalian posterolateral cortical amygdala and amygdalopiriform transition 
area, which also express Wfs1, but less than Pir (Ref I Fig. 2; Ref II Table 1). 
The question about the evolution of the tetrapodean pallium has been most 
extensively brought under attention in studies on avian brain and it has given 
rise to fervent debates between scientists (Jarvis et al., 2005; Montiel and 
Molnár, 2013). Thus, the consensus in the homology between avian and 
mammalian pallial amygdala is still lacking these days. Whereas some authors 
consider the avian ADo and core nucleus of the amygdala (ACo) homologous to 
the mammalian basolateral (BL) and basomedial (BM) amygdaloid complex 
(Martínez-García et al., 2009), others argue that ADo and ACo correspond to 
the mammalian neocortical layers V and IV, respectively (Reiner et al., 2004; 
Reiner et al., 2005). The developmental dynamics of Wfs1 in the afore-
mentioned structures in the chick and mouse brain (see chapter 1 in this section) 
does not contradict with either proposal of homology. However, the role of the 
avian posterior arcopallium in the regulation of fear behaviour advocates for the 
homology to the mammalian pallial amygdala (Saint-Dizier et al., 2009). We 
did not perform the developmental gene expression study on the turtle brain, 
therefore, we cannot make conclusions about the developmental dynamics of 
the expression of Wfs1 in the turtle caudal DVR, the counterpart of mammalian 
BM and BL according to Bruce et al., 2009, and Martínez-García et al., 2009. 
Nevertheless, the ventricular edge of the caudal DVR was one of the strongest 
Wfs1 expression sites in the turtle brain (Ref II, Fig. 7D), which might reflect 
the evolutionary conservation of Wfs1 expression in the ventral and lateral 
pallial derivatives.  
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In conclusion, our results suggest the common ancestral pattern of Wfs1 
expression in the subpallium. On the development of pallium, we favour the 
position that the expression of Wfs1 is conserved in the pallial amygdaloid 
structures and perhaps in the hippocampal complex but gained independently in 
the derivatives of the dorsal pallium and subset of lateral pallial derivatives 
across the three evolutionary lineages studied. 
On the development of pallium, we favour the position that the expression of 
Wfs1 is conserved in the pallial amygdaloid structures and perhaps in the 
hippocampal complex but gained independently in the derivatives of the dorsal 




4. Wfs1 is expressed in the brain regions that receive 
dopaminergic input and it influences the number of 
ligand binding sites of D1-like receptor (Ref II) 
Since Wfs1-/- mice display alterations in their dopaminergic system (Luuk et al., 
2009; Matto et al., 2011; Visnapuu et al., 2013a) and Wfs1 is expressed in the 
brain regions that are known as targets of the dopaminergic pathways, such as 
ventral and dorsal striatum, hippocampus, central extended amygdala and 
cerebral cortex (Björklund and Dunnett, 2007; Wise, 2004), we aimed to take 
the relation of WFS1 and dopamine system under a closer investigation. We 
decided to study the relation between WFS1 and D1-type dopamine receptors, 
since the D1-type receptors are the most widespread dopamine receptors in the 
brain, being present in many Wfs1-expressing regions (Missale et al., 1998).  
The mRNA expression of the two D1-type dopamine receptors, Drd1a (also 
known as Drd1 in mammals) and Drd5, was rather evenly distributed through-
out the mouse brain, with Drd1a showing more expression in the striatum and 
Drd5 in the cortical structures and amygdala (Ref II, Fig. 1B, C, E, F, H, I, K, 
L, N, O). The immunohistochemical evaluation showed more specific 
confinement of both proteins to the well-known dopaminoceptive regions (Ref 
II, Fig. 3E-L). The expression pattern of D1-like dopamine receptors, especially 
that of DRD1A, was resembling the expression of WFS1 on the protein level 
(Ref II, Fig. 3, Fig. 4). In the chick brain, the mRNA expressions of Wfs1 and 
Drd1a were almost completely overlapping (Ref II Fig. 5A-H, J, K). Likewise, 
in the turtle brain, the anatomical distributions of Wfs1 and Drd1a mRNA were 
considerably similar (Ref II, Fig. 7).  
Inspired by the largely overlapping expression pattern of Wfs1 and Drd1a, 
we decided to examine the D1-like receptor specific dopaminergic transmission 
in wt and Wfs1 KO mice. For this, we assayed the radioactive ligand binding of 
D1-like receptors in the hippocampi of wt and Wfs1-/- mice. We found that the 
ligand binding was increased in the Wfs1-/- hippocampi, indicating that Wfs1 KO 
mice have more D1 receptor ligand binding sites than the wt mice (Fig. 6, same 
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as Ref II, Fig. 9). We propose that the increase in the D1-like receptor binding 
sites reflects a homeostatic change in response to pre- or postsynaptic variation 
of dopaminergic signalisation in the Wfs1-/- mice. It could be directly caused by 
the lack of WFS1 in the postsynaptic cells or alternatively reflect a compen-
satory change in response to the reduced dopamine output, as shown in the 
striatum of the Wfs1-/- mice (Matto et al., 2011). Since the intracellular environ-
ment is severely affected in WFS1 deficient neurons (Cagalinec et al., 2016), it 
could be the case that signal transduction pathways commencing from D1 
receptor are deranged in Wfs1 deficiency. Regarding that the D1-like receptors 
mediate changes in intracellular calcium levels (Lin et al., 1995; Liu et al., 
1992; Surmeier et al., 1995; Swapna et al., 2016), lack of WFS1 is likely to 
interfere with these processes. 
 
Figure 6. Binding of D1-type dopamine receptor specific ligand [3H]SCH23390 to 
hippocampal membranes of wt and Wfs1-/- mice. (A) Binding curve of [3H]SCH23390 
binding to pooled hippocampal samples of wt (triangle) and Wfs1-/- (circle) mice. The 
membrane suspensions (3 mg/well) were incubated with different concentrations of 
[3H]SCH23390 for 60 min and bound radioactivity was measured. Data are presented as 
mean ± SEM from experiments (n = 3) performed in duplicates. (B) The level of 
[3H]SCH23390 binding sites of individual wt and Wfs1-/- mice determined in hippocampal 
membrane suspensions (6.7 mg/ml) incubated with 4 nM radioligand. Data are presented 
as mean ± SEM of all the mice tested. *p < 0.05. Same as Fig. 9 in Ref II. 
 
 
The upregulation of D1-like receptors could explain the increased sensitivity of 
Wfs1-/- mice to the locomotor stimulatory effect of dopamine receptor agonist 
apomorphine (Luuk et al., 2009). Other significant changes in the functioning of 
the dopaminergic system of Wfs1 KO mice include the reduced level of 
dopamine transporter (DAT) mRNA expression in the midbrain, reduced 
expression of dopamine receptor 2 (Drd2) in the dorsal striatum of the male in-
dividuals, and reduced sensitivity to the presynaptic dopamine agonist 




In our study, we did not evaluate the abundance or expression pattern of D2-
like dopamine receptors. In contrast to D1-like receptors, D2-like receptors 
inhibit the adenylyl cyclase activity (Missale et al., 1998) and are predominantly 
expressed on different cells, at least in the dorsal and ventral striatum (Valjent 
et al., 2009). Therefore, it would be essential to find out if on the cellular level 
WFS1 colocalizes with D1- or D2-like receptors and/or if D2-receptor binding 
is affected in Wfs1-/- mice. In addition, the functioning of the intracellular path-
ways of both D1- and D2-like receptors should be studied in Wfs1-/- mice.  
Curiously, the genetic deletion of calcium/calmodulin dependent adenylyl 
cyclases affects the same behavioural characteristics as the invalidation of Wfs1 
gene. Adenylyl cyclase 8 (AC8) KO mice show altered stress-induced anxiety 
(Bernabucci and Zhuo, 2016; Schaefer et al., 2000) and adenylyl cyclase 1/8 
double KO mice display deficit in hippocampus-dependent long-term memory 
(Wong et al., 1999), which is also slightly impaired in Wfs1-/- mice (Luuk et al., 
2009). In addition, adenylyl cyclase 1/8 double KO mice show dysregulated 
dopamine homeostasis in the ventral striatum and display reduced locomotor 
stimulation by methamphetamine, as well as attenuated behavioural sensiti-
zation upon repeated treatment with methamphetamine (Bosse et al., 2015). 
These findings resemble the phenotype of Wfs1-/- mice (Luuk et al., 2009; 
Visnapuu et al., 2013a). Furthermore, fear conditioning elevated the level of 
Wfs1 expression in the hippocampus of wt mice but failed to do so in adenylyl 
cyclase 1/8 double KO mice (Wieczorek et al., 2010). 
The hippocampal expression of AC8 is restricted to the CA1 region similarly 
to Wfs1 (Schaefer et al., 2000; Wei et al., 2002). AC8 KO mice display lack of 
stress-induced CREB phosphorylation specifically in the CA1 region of the 
hippocampus, which probably underlies the deficiency in experience-dependent 
fear memory in these mice (Schaefer et al., 2000). To investigate the possible 
role of WFS1 in the D1 dependent adenylyl cyclase activation, measuring the 
intracellular cAMP and the activation of cAMP-dependent pathways in 
response to D1-receptor agonist in Wfs1-deficient neurons would be the next 




5. The differential expression of the two alternative 
transcripts of Lsamp gene correlates with  
the measures of trait anxiety and social interaction 
(Ref III) 
Similarly to Wfs1, Lsamp is highly expressed in the brain regions involved in 
emotional circuits and its expression level in the temporal lobe changes in 
response to predator-related stimulus. After revising the genomic structure of 
Lsamp gene, two alternative promoters were described in 2004 by Pimenta and 
Levitt (Pimenta and Levitt, 2004). Although the protein expression pattern is 
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studied in several species (Brümmendorf et al., 1997; Chesselet et al., 1991; 
Côté et al., 1995; Côté et al., 1996; Levitt, 1984; Yamamoto and Reiner, 2005; 
Yamamoto et al., 2005) and mRNA expression is described in both foetal and 
adult rat brain (Pimenta et al., 1996b; Reinoso et al., 1996), the activity pattern 
of 1a and 1b promoters of the Lsamp gene had not been addressed. Therefore, 
we aimed to provide an anatomical overview of the alternative promoter activity 
in the adult and developing mouse brain. Although including or omitting exons 
7 and 8 adds additional variation to the Lsamp transcripts (see Fig. 3), we 
distinguished the transcripts only based on the 5`end encoding the signal 
peptide. For simplicity, the transcripts obtained from the alternative promoters 
are called 1a and 1b transcript in this study. To better understand the importance 
of the Lsamp 1a and 1b transcripts, we examined the role of each transcript in 
relation to trait anxiety and social behaviour.  
We found that the expression pattern of the two alternative transcripts was 
discernibly complementary, as Lsamp 1a transcript prevailed in the classical 
limbic structures (see Fig. 7) and 1b transcript was more abundant in the brain 
regions associated with sensory functions. Of the classical limbic structures 
(Heimer and Van Hoesen, 2006; Morgane et al., 2005), Lsamp 1a was strongly 
expressed in the hippocampus, ventral striatum, in limbic cortices including 
piriform, prelimbic, infralimbic, cingulate, insular and retrosplenial granular 
cortex, amygdala (nucleus of the lateral olfactory tract, lateral, basolateral, 
medial, posterolateral and posteromedial cortical nuclei), amygdalohippocampal 
transition area, dorsal lateral septum and medial preoptic area (Ref III, Fig. 1e-
h, Fig. 2b, f, j, Fig. S1e, f, k). In general, the activity of Lsamp 1b promoter was 
much lower or not present in these structures. Of the limbic structures, 
considerable activity of Lsamp 1b promoter was present in the lateral septum, 
piriform cortex, and in some nuclei of the amygdala (central amygdala, 
posterolateral and posteromedial cortical amygdala; Ref III, Fig. 1i-l, Fig. 2c-d, 
g-h, k-l). 
In the thalamus, Lsamp 1a promoter activity tended to localize into limbic-
related nuclei, while 1b was active in several limbic-related nuclei and in 
numerous regions ascribed to participate in sensory communication. Lsamp 1a 
promoter activity was outstanding in the anterior thalamic nuclei, including 
anterodorsal (AD) and anteroventral (AV) nucleus (Ref III, Fig. S1g). In the 
AD, also 1b promoter was strongly activated (Ref III, Fig. S1h). The anterior 
thalamic nuclei are interconnected with the limbic structures such as hippo-
campus, retrosplenial and entorhinal cortices, and mediate the formation of 
contextual fear memory (Marchand et al., 2014; Shibata, 1993; Wright et al., 
2010). Paraventricular nucleus of the thalamus, which showed strong activity of 
both Lsamp 1a and 1b promoters (Ref III, Fig. S1g, h, k, l), receives extensive 
innervation by orexin, corticotropin-releasing hormone and monoamines and is 
reciprocally connected to numerous brain areas involved in emotion processing 
and motivation (Hsu et al., 2014). Lsamp 1a expression was strong in the 
parafascicular nucleus of the thalamus (PF), that mainly has connections to the 
brain regions involved in somatosensory and motor functions (Berendse and 
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Groenewegen, 1990; Cornwall and Phillipson, 1988). Together with the 
paracentral thalamic nucleus, where both Lsamp promoters were active, it 
belongs to the group of intralaminar thalamic nuclei, which are involved in 
behavioural flexibility and decision making (Bradfield et al., 2013; Brown et al., 
2010) and nociceptive processing related to the affective and motivational 
aspects of pain (Sewards and Sewards, 2002; Sugiyo et al., 2006).  
 
Figure 7. The expression of Lsamp 1a 
transcript during the development of 
emotional circuits. mRNA in situ hybridi-
zation. Lsamp 1a transcript is widely 
expressed in the limbic-related anterior, 
midline and intralaminar thalamic nuclei, 
medial preoptic area, parts of the ex-
tended amygdala (IPAC, BSTL, BSTM) 
and specifically during the development 
in the anterior CPu. Abbreviations: aCPu-
anterior caudate-putamen, AD-antero-
dorsal thalamic nucleus, AV-anterovent-
ral thalamic nucleus, BSTL-lateral bed 
nucleus of stria terminalis, BSTM-medial 
bed nucleus of stria terminalis, CM-
central medial thalamic nucleus, h-hippo-
campus, IPAC- interstitial nucleus of the 
posterior limb of the anterior commissure, 
MD-mediodorsal thalamic nucleus, MHb-
medial habenula, MPON-medial preoptic 
nucleus, PV-paraventricular thalamic 
nucleus, Rt- reticular thalamic nucleus. 
Scale bar 1 mm. 
 
 
The activity of Lsamp 1b promoter well delineated auditory, visual and 
somatosensory pathways in the brain, being present in the brainstem sensory 
nuclei, thalamic relay nuclei and primary and secondary cortices of the 
respective perceptive fields. Along the auditory pathway, Lsamp 1b promoter 
was active in the dorsal and ventral cochlear nucleus, trapezoid body, superior 
olivary complex, lateral lemniscus, inferior colliculus, medial geniculate 
nucleus of the thalamus (MG), and auditory cortices (Ref III, Fig. 1j-k, Fig. 
S1n-p). Inferior colliculus functions as the integrator of auditory information to 
multi-modal sensory perception and passes the information on to the MG. MG 
represents the thalamic relay of the auditory pathway, passing information to 
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the auditory cortex, ibid sending projections to several subcortical areas in-
volved in emotional behaviour and autonomic function (central and lateral 
amygdala; caudate-putamen; ventromedial hypothalamus; LeDoux et al., 1984). 
In the visual system there was intensive Lsamp 1b transcript-specific 
staining in the superior colliculus (SC), dorsal lateral geniculate nucleus (DLG), 
lateral posterior thalamic nucleus (LP), and primary and secondary visual cortex 
(Ref III, Fig. S1n, Fig. 1j-l). DLG is the major thalamic relay receiving visual 
information from the retina and providing input to the primary visual cortex 
(Guillery and Sherman, 2002). LP integrates signals from the SC, cortex and 
retina and communicates with both higher visual cortical areas and subcortical 
sites, such as the amygdala, linking visual signals to emotional salience (Kaas 
and Lyon, 2007; Wei et al., 2015). 
The brainstem nuclei of the somatosensory pathways, namely spinal 
trigeminal nucleus, solitary nucleus and cuneate nucleus were expressing Lsamp 
1b transcript, as their thalamic targets ventral posteromedial nucleus (VPM), 
ventral posterolateral nucleus (VPL) and posterior thalamic nuclear group, and 
the somatosensory cortex (Ref III, Fig. 1i-k, Fig. S1s).  
Both Lsamp 1a and 1b promoters were active in the brain regions associated 
with gustatory and olfactory perception, which is in accordance with the 
involvement of these brain regions (e.g. insular, piriform and entorhinal 
cortices, amygdala) in emotion processing. While the solitary nucleus and 
VPM, that are involved in mediating the taste signals, showed the activity of 
Lsamp 1b promoter (Ref III, Fig. 1i-k, Fig. S1s), the insular cortex, which is the 
cortical target of the gustatory pathway (Matsumoto, 2013), was exclusively 
expressing Lsamp 1a transcript (Ref III, Fig. 2b, f, Fig. S1e, f). In the olfactory 
system, the olfactory bulb, mediodorsal thalamic nucleus (MD; Ref III, Fig. 1i, 
Fig. 2k-l), and entorhinal cortex (Ref III, Fig. S1n) showed 1b specific X-gal 
staining, while the expression of 1a transcript was prevailing in the olfactory 
tubercle (Ref III, Fig. 2b, f) and piriform cortex (Ref III, Fig. 1e-h, Fig. S1k). In 
the nucleus of the lateral olfactory tract, which integrates olfactory and 
vomeronasal information (Pro-Sistiaga et al., 2007; Vaz et al., 2017), the 
expression of Lsamp 1a was distinctly strong, while no 1b activity was observed 
in this nucleus (Ref III, Fig. S1k). 
In the sensory cortices, the promoter 1b was active in layers IV and VI (Ref 
III, Fig. S1d), underlining the distribution of 1b transcript in the brain regions 
involved in sensory processing. Layer IV is the major target for the thalamic 
afferents (Benshalom and White, 1986; Staiger et al., 1996) and layer VI is the 
main cortical layer that sends feedback to the thalamic nuclei (Lam and Sher-
man, 2010).  
Both Lsamp 1a and 1b promoter were highly active in the medial habenula 
(MHb; Ref III, Fig. 1e, i, j), while the lateral habenula (LHb) showed moderate 
activity of 1b promoter (Ref III, Fig. 1i). Together with the bed nucleus of the 
anterior commissure, which also showed strong 1b promoter activity (Ref III, 
Fig. 2h), the MHb is part of septo-habenular pathway which is implicated in 
anxiety and fear responses (Yamaguchi et al., 2013). The neural pathway from 
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MHb to its main output target interpeduncular nucleus is involved in both ad-
diction to multiple drugs of abuse and mood-associated conditions (McLaughlin 
et al., 2017). Neurons of the LHb participate in predicting negative rewards by 
sending inhibitory signals to the midbrain dopaminergic neurons upon cues 
associated with lack of reward (Matsumoto and Hikosaka, 2007). 
Lsamp mRNA was rather widely distributed in the hypothalamus (Ref III, 
Fig. 1a-d, Fig. 2e, i), but the expression regions of the two alternative transcripts 
were generally segregated. Strong expression of 1a transcript was present in the 
dorsomedial and ventrolateral parts of the ventromedial hypothalamus (VMH; 
Ref III, Fig. 1e), which is involved in feeding, fear, aggression and sexual 
behaviour (King, 2006; Lin et al., 2011; Silva et al., 2013; Yang et al., 2017). 
Lsamp 1b-specific staining was present in the anterior part of the VMH (Ref III, 
Fig. 2k). Dorsomedial hypothalamus (DM), which functions as a thermo-
regulatory centre and integrator of autonomic, endocrine and behavioural 
responses to emotional stress (Fontes et al., 2011), showed strong 1a promoter 
activity (Ref III, Fig. 1f) as well as 1b specific X-gal staining in its compact 
subdivision (Ref III, Fig. 2l). Lsamp 1a transcript expression was remarkably 
strong in the medial preoptic area (Ref III, Fig. 2f), which provides important 
inhibitory input to the DM (Hunt et al., 2010) and is involved in 
thermoregulation, maternal behaviour, and sexual behaviour (Boulant, 2000; 
Stolzenberg and Numan, 2011). In the caudal hypothalamus, mammillary 
bodies, which belong to the spatial memory circuit joining ventral tegmentum 
and hippocampus with the anterior thalamic nuclei (Dillingham et al., 2015), 
originally proposed by Papez as the central circuit for emotion (Papez, 1937; 
Shah et al., 2012), were strongly expressing Lsamp 1a and 1b (Ref III, Fig. 1g-
h). Moderate Lsamp 1a transcript expression was seen in the lateral 
hypothalamus (Ref III, Fig. 1f-g), which is involved in feeding, arousal and 
reward-seeking, and is the source of orexin/hypocretin input to various brain 
regions (Peyron et al., 1998; Stuber and Wise, 2016). Paraventricular 
hypothalamic nucleus (Pa) was one of the few hypothalamic regions, where the 
activity of both 1a and 1b promoters was strongly represented (Ref III, Fig. 
S1k-l). Pa contains different neurosecretory cells that produce various peptide 
hormones and neurotransmitters, including oxytocin, vasopressin, corticotropin-
releasing hormone (CRH) and thyrotropin-releasing hormone (TRH), and it 
constitutes an important output station for the hypothalamo-pituitary-adrenal 
axis involved in stress regulation (Herman et al., 2003). The activity of Lsamp 
1b promoter circumscribed the neuropeptide-producing nuclei of the 
hypothalamus: in addition to the Pa, 1b promoter was active in the peri-
ventricular (Ref III, Fig. 1i, Fig. S1i, j, l), anteroventral periventricular (Ref III, 
Fig. 2g, h), suprachiasmatic (Ref III, Fig. S1i, j, l), supraoptic (Ref III, Fig. S1l) 
and arcuate nucleus (Ref III, Fig. 1j, k).  
Distinct pattern of Lsamp promoter activity was evident in the cerebellum. 
Lsamp 1b-specific staining was strong in the Purkinje cell layer and moderate in 
the molecular layer (Ref III, Fig. S1r), while the granule cell layer was weakly 
expressing 1a transcript (Ref III, Fig. S1q). The granule cell layer is the 
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principal glutamatergic cell layer in the cerebellum, which receives input from 
the cerebrum and sends projections to the Purkinje cells and to the molecular 
layer. The output of the cerebellum is the inhibitory signal from the Purkinje 
cells to the deep cerebellar nuclei. The Purkinje cells, in turn, are inhibited by 
the GABAergic cells of the molecular layer. This circuit is responsible for the 
motor coordination and a multitude of cognitive and emotional processing tasks 
(Saab and Willis, 2003).   
In the developing brain, we detected the first signals for both promoters of 
the Lsamp gene at around E12.5. The expression of Lsamp 1a transcript first 
appeared in the outer layers of the neural tube (Ref III, Fig. 3a, b); conversely, 
the activation of 1b promoter marked the proliferative zone, lining the 
ventricular side of the developing striatum (Ref III, Fig. 3d, e). By E15.5, 
Lsamp 1b promoter activity was also present in the lining of the aqueduct and in 
the deep cortical layers near the corticostriatal junction (Ref III, Fig. 3f). The 
main expression regions of Lsamp 1a transcript in E15.5 brain were the piriform 
cortex, superficial part of the somatosensory cortical region and deeper zone of 
the remaining cortical plate, medial amygdala, anterior thalamus and the CPu 
(Ref III, Fig. 3c). Interestingly, Lsamp mRNA is almost lost from the CPu in the 
adult brain (Ref III, Fig. 2a-c, e-g), where weak 1a expression remains only in 
the anterior CPu (Ref III, Fig. 2b) and the caudal-most region shows activity of 
1b promoter (Ref III, Fig. 1j). This suggests for the specific role of LSAMP 
during the development of the dorsal striatum. In the lateral habenula, LSAMP 
takes part in guiding the growing dopaminergic axons (Schmidt et al., 2014), 
which form a feedback loop between the ventral tegmental area (VTA) and LHb 
to signal the positive or negative rewarding value of the stimuli (Shen et al., 
2012, Stamatakis et al., 2013). The CPu displays heterogenous LSAMP protein 
expression in its striosomal vs matrix compartments, suggesting for the segre-
gation of limbic-related connections in relation to the nature of dopaminergic 
input (Chesselet et al., 1991). Therefore, the role for LSAMP in the correct 
dopaminergic innervation of the CPu can be hypothesized and needs further 
study. 
Pimenta et al., 1996b report the first appearance of the 8.0 kb transcript of 
Lsamp gene (later referred to as 1a transcript) at E15.5 in the hindbrain of the 
rat, while 1.6 kb transcript (later referred to as 1b transcript) first appeared in 
the hindbrain of E12.5 rat. Presence of Lsamp expression at this early age 
precedes active neurite outgrowth and path-finding, suggesting that Lsamp is 
important already at the time of neuroepithelial patterning. Horton and Levitt, 
1988 argue that LSAMP immunoreactivity appears 24 – 36 hours after the 
neurons undergo the final mitosis and predates the occurrence of synaptic 
transmission, probably reflecting the designation as a part of the limbic circuitry 
almost from the time of the initial differentiation. In the anterior-most end of the 
chick embryo, Lsamp mRNA is already present at the stage of three primary 
brain vesicles (Hamburger-Hamilton stage 10). By stage 14 (E2), Lsamp mRNA 
is expressed in the midbrain, neural crest cells and notochord, and by stage 25 
(approximately E5), instead of notochord, the expression is found in the floor 
57 
plate and motoneuron columns (Kimura et al., 2001). The expression of the two 
alternative transcripts of the Lsamp mRNA undergoes developmental changes 
in the chick brain (Brümmendorf et al., 1997). Somewhat counter-intuitively, in 
the chick brain, Lsamp 1a transcript (referred to as g11/g19 form) is present at 
earlier stages compared to Lsamp 1b transcript (referred to as g9 form; 
Brümmendorf et al., 1997). Altogether, it is evident that the distinct develop-
mental regulation of the two Lsamp transcripts in both rodent and chick brain 
underlines the significance of the alternative promoter activity in the develop-
ment of the nervous system. 
Comparing the present results with the protein expression in the embryonic 
rat brain described by Horton and Levitt, 1998 suggests that the LSAMP protein 
expression resembles more the distribution of Lsamp 1a transcript around E15. 
The distribution of LSAMP protein is also described in the adult rat (Levitt, 
1984; Reinoso et al., 1996). For better overview, the comparison between 
protein expression described in the rat brain by Levitt et al., 1984 and Reinoso 
et al., 1996 and Lsamp 1a and 1b promoter activity studied in Ref III is pre-
sented in the Table 3 in the 6-th chapter of Results and Discussion. 
In general, the expression of LSAMP protein is more similar to the regional 
distribution of Lsamp 1a transcript, as the limbic-specific identity suggests. 
Particularly, the protein expression studied by Levitt, 1984 mirrors the expres-
sion of 1a transcript. Nevertheless, several regions showing only Lsamp 1b 
promoter activity are expressing LSAMP protein, including entorhinal and 
somatosensory cortices, CPu, globus pallidus, sensorimotor thalamus (latero-
dorsal, mediodorsal, ventral posterolateral and posteromedial, ventrolateral, 
ventromedial, dorsal lateral and medial geniculate and posterior thalamic 
nuclei), lateral habenula, inferior and superior colliculi of the midbrain, sensory 
and motor nuclei of the brainstem, as well as molecular and Purkinje cell layer 
of the cerebellum (Levitt, 1984; Reinoso et al., 1996; Ref III, Fig. 1i-l, Fig. 2k, 
l, Fig. S1m-p, r, s, Supplementary table S2; Table 3). In addition, several 
neuropeptide-producing nuclei, including periventricular hypothalamic nucleus, 
anteroventral periventricular hypothalamic nucleus, supraoptic, suprachiasmatic 
and arcuate nucleus were among those where LSAMP protein expression was 
reduplicating the activity of Lsamp 1b promoter. Thus, from the comparison of 
Lsamp transcript and protein expression, two patterns emerge: the protein is 
made from solely 1b transcript in several sensory and motor regions and 
additionally, in most of the neurosecretory nuclei that express Lsamp.  
As the somatomotor system is inevitably interconnected with the limbic 
system, the presence of LSAMP in the sensory and motor brain regions might 
be the witness of such association. In this context, special attention must be paid 
on the cerebellum as the powerful processing centre for cognitive, emotional 
and memory-related functions. Renowned for its role in motor coordination, the 
cerebellum is also involved in coordinating thought, affection, memory and 
language processes (Stoodley and Schmahmann, 2010). Thus, in the cere-
bellum, LSAMP could take part in the formation and maintenance of the 
emotion-related connectivity. In the dentate nucleus, which is one of the main 
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output stations of the cerebellum, the projections to and from different cortical 
regions are arranged in a topographic manner, forming a map of multiple 
closed-loop circuits (Dum and Strick, 2003). Considering the function of 
LSAMP and other IgLON family proteins in the formation of neural circuits, it 
is plausible that their expression could be required to establish such 
connectivity. It is important to note that most of the IgLON family genes are 
expressed in the cerebellum and in all dual promoter IgLON genes including 
Lsamp, Opcml and Ntm, 1b transcript is strongly prevailing in the cerebellum 
(Vanaveski et al., 2017).  
Among the neurosecretory nuclei, the Pa, which is one of the most important 
neuroendocrine centres in the brain (Ferguson et al., 2008), outstands as an 
exception. In addition to strong Lsamp 1b activity, it moderately expressed 1a 
transcript (Ref III, Fig. S1k, l) and shows high LSAMP protein levels in its 
magnocellular part and low protein levels in the parvocellular part (Reinoso et 
al., 1996). Levitt, 1984 did not detect LSAMP protein expression in the Pa, the 
controversy might arise from the highly heterogenous structure of this nucleus 
(Swanson and Kuypers, 1980). 
Another member of the IgLON family, OPCML/OBCAM is present in the 
neurosecretory granules in the vasopressin-secreting magnocellular neurons of 
the supraoptic and paraventricular nuclei of the hypothalamus (Miyata et al., 
2003). Similarly to Lsamp, Opcml gene possesses two evolutionarily conserved 
alternative promoters leading to separate transcripts (1a and 1b) which are 
differentially expressed across the brain and yield an identical protein (Vana-
veski et al., 2017). Concerning the pattern of Lsamp 1a and 1b promoter activity 
in comparison with the protein expression (see Table 3), it is intriguing to guess 
that in some neurosecretory nuclei (periventricular hypothalamic nucleus, 
supraoptic nucleus, suprachiasmatic nucleus and arcuate nucleus), where only 
Lsamp 1b promoter was active, LSAMP protein might be targeted to the neuro-
secretory granules. To elucidate the functional significance of the two alterna-
tive promoters, this question should be addressed in the future studies. 
Regarding the ultrastructural distribution of LSAMP protein, it has been 
proposed that LSAMP fulfils different roles in the developing and adult brain 
(Zacco et al., 1990). During the development, LSAMP protein is extensively 
expressed on the surface of fasciculating axons (Horton and Levitt, 1988), 
whereas in the adult brain, only cell bodies and dendrites show LSAMP 
immunoreactivity (Zacco et al., 1990). While at P10, LSAMP is present in both 
pre- and postsynaptic membranes of the developing synapse in rat, it proves 
exclusively postsynaptic in adulthood (Zacco et al., 1990). Fimbria/fornix and 
corpus callosum, fibre tracts that transiently express LSAMP, lose the 
expression during the third postnatal week in the rat (Horton and Levitt, 1988; 
Zacco et al., 1990). 
The developmentally transitory presence of LSAMP in the axons is in line 
with the participation in the axon growth and guidance (Eagleson et al., 2003; 
Keller et al., 1989; Mann et al., 1998). LSAMP has been shown to specifically 
promote the growth of limbic thalamic and cortical axons while inhibiting the 
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growth of nonlimbic thalamic axons (Mann et al., 1998) and facilitate the target 
invasion and collateralization of the septohippocampal axons (Keller at al., 
1989). The neurite outgrowth- and adhesion-promoting activity of LSAMP 
(Pimenta et al., 1995; Zhukareva and Levitt, 1995) is mediated by its first Ig-
domain, whereas interactions involving the second Ig domain mediate the 
inhibition of neurite outgrowth in heterophilic manner (Eagleson et al., 2003). 
One such heterophilic binding partner of LSAMP is Neurotrimin. Neurotrimin 
and LSAMP show rather complementary protein distribution in the rodent brain 
(in somatosensory and motor vs limbic brain regions; Gil et al., 2002), and their 
interaction inhibits neurite outgrowth, whereas both can promote neurite 
outgrowth in homophilic manner (Gil et al., 1998; Gil et al., 2002; Sanz et al., 
2015). In the dorsal root ganglia, LSAMP inhibits neurite outgrowth and the 
attenuation of the inhibition occurs through LSAMP ectodomain shedding by 
metalloproteinase ADAM10 (Sanz et al., 2017).  
In contrast to the rather wide evidence of the involvement of LSAMP in the 
neurodevelopmental processes, the role of LSAMP in the adult brain remains 
elusive. Considering its strong expression in the dendritic compartments of the 
limbic system neurons, one can hypothesize that it might take part in the 
activity-dependent remodelling of the neural network. Since LSAMP is present 
in the postsynaptic membrane in the adult rat (Zacco et al., 1990) and it can 
promote synaptogenesis in the hippocampus (Hashimoto et al., 2009), it is 
probable that it might take part in the plasticity or formation of synapses in the 
adult brain. In our laboratory, it has been shown that LSAMP is involved in the 
regulation of environmental enrichment-induced brain-derived neurotrophic 
factor (Bdnf) expression (Heinla et al., 2015). BDNF is a crucial regulator of 
proliferation, survival, differentiation, synaptogenesis and activity-dependent 
synaptic plasticity in neurons (reviewed in Binder and Scharfman, 2004; Gott-
mann et al., 2009). The lack of enrichment-induced elevation in Bdnf expression 
in the hippocampi of adult Lsamp-/- mice suggests that LSAMP could serve as a 
positive modulator of BDNF regulated neuronal pathways (Heinla et al., 2015). 
This assumption is further supported by the finding that the expression levels of 
Lsamp 1a and 1b transcripts positively correlate with the expression of Bdnf in 
the hippocampus and frontal cortex of mice (Heinla et al., 2015). 
To elucidate the functional significance of the two alternative Lsamp pro-
moters, we studied the expression level of Lsamp 1a and 1b in relation to the 
anxiety-related and social behavioural characteristics of mice. First, behavioural 
parameters in the motility box and elevated plus maze were compared to the 
expression level of Lsamp gene transcripts in the hippocampus, temporal lobe 
and ventral striatum. The results are presented in the Table 2 (same as Table 1 
in Ref III). While there were no significant correlations between the Lsamp 
transcript expression and behavioural parameters in the motility box, the 
exposure to elevated plus maze revealed correlations between the anxiety-
related behaviour and the expression of Lsamp transcripts. The expression level 
of Lsamp 1a transcript in the temporal lobe showed correlation with several 
behavioural measures in the plus maze: it was negatively correlated with the 
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number of open arm entries, time spent on open arms, ratio between open and 
closed arm entries, and number of unprotected head-dips, and positively 
correlated with the latency before entering the open arm. The time spent on 
open arms was also negatively correlated with the level of Lsamp 1b transcript 
expression in the temporal lobe.  
Secondly, a social interaction test was carried out, where two unfamiliar 
mice were put in the same cage and the time spent sniffing the partner`s 
anogenital area as well as other body parts and total time of social sniffing was 
recorded. In the hippocampus, the expression of both Lsamp 1a and 1b 
transcript negatively correlated with the time spent sniffing other body parts 
besides the anogenital area. In the ventral striatum, the expression level of 
Lsamp 1a correlated positively with the time involved in anogenital sniffing.   
 
Table 2. Correlation analysis between relative expression levels (2−ΔCT) of Lsamp 1a 
and 1b transcript in three brain areas and behavioural parameters in the motility box, 
elevated plus-maze and social interaction test. Table 1 in Ref III. 




1a 1b 1a 1b 1a 1b 
Motility box       
Move, s −0.01 −0.06 0.11 0.06 0.12 −0.34 
Distance, m −0.06 −0.16 0.19 0.08 0.05 −0.30 
Time centre, s −0.40 −0.36 0.43 0.36 0.05 0.03 
Time corner, s 0.21 0.33 −0.38 −0.10 −0.13 0.17 
Elevated plus maze       
Closed arm entries −0.20 −0.43 0.17 −0.02 0.08 −0.14 
Open arm entries 0.16 0.16 −0.57* −0.40 0.01 −0.34 
Ratio open/closed arm 
entries 
0.08 0.13 −0.63 * −0.38 −0.11 −0.34 
Latency, s 0.03 −0.01 0.53* 0.22 −0.15 0.45 
Time on open arms, s 0.24 0.15 −0.65** −0.66** 0.14 −0.21 
Protected headdips 0.17 0.08 −0.06 −0.06 −0.12 −0.26 
Unprotected headdips 0.10 0.12 −0.61* −0.50 0.20 −0.40 
SAPs −0.05 0.10 0.24 0.23 0.11 0.17 
Social interaction test       
Anogenital sniffing, s −0.10 −0.22 −0.09 −0.26 0.54* 0.11 
Sniffing other body parts, s −0.67** −0.65* 0.06 0.15 −0.19 −0.07 
Time of social sniffing, s −0.51 −0.60* −0.01 −0.09 0.14 −0.06 
The behavioural measures have been presented in either counts, seconds (s) or meters (m). 
* p < 0.05, ** p < 0.01 (Spearman’s rank-order correlation) 
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In the second part of the behavioural studies, we investigated the influence of 
acute fear reaction on the expressional activity of the Lsamp gene. Mice were 
divided into three groups: 1) experimentally naïve mice, 2) mice that underwent 
fear conditioning (15 s tone and pulsing bright light terminated by electric 
shock) but did not receive treatment on the day of tissue collection, and 3) mice 
that underwent fear conditioning and were exposed to the conditioned stimuli 
prior to tissue collection. We did not detect changes in the expression of Lsamp 
transcripts in the temporal lobe or hippocampus between the groups on the 
selected time point, 45 minutes after the onset of the exposure to the condi-
tioned stimuli (Ref III, Fig. 4e). Nevertheless, the rise in neural activity in the 
temporal lobe and hippocampus was confirmed by measuring the expression 
level of immediate early gene c-Fos. In the 3rd group of mice that were exposed 
to the conditioned stimuli prior to tissue collection, c-Fos expression was up-
regulated in both, temporal lobe and hippocampus (Ref III, Fig. 4d). Stronger 
upregulation in the temporal lobe vs hippocampus reflected the specific acti-
vation of the amygdaloid area in response to conditioned fear. 
Previously, changes in the expression level of Lsamp have been implicated 
in predator-associated fear and fear of pain. Exposure of rats to cat odour (Kõks 
et al., 2004) and electric foot shock (Lamprecht et al., 2009) increased the ex-
pression of Lsamp mRNA in the amygdala. In addition, Lsamp shows link to 
trait anxiety. Increased level of Lsamp mRNA in different brain regions in-
volved in behavioural control (amygdala, periaqueductal grey, raphe nuclei, 
hippocampus and frontal cortex) has been associated with lower exploratory 
activity and higher level of anxiety (Alttoa et al., 2010; Nelovkov et al., 2006). 
However, the importance of the Lsamp 1a and 1b transcripts in fear and anxiety 
related behaviour had not been addressed before. Our results, which showed the 
elevation of Lsamp 1a and 1b transcripts in the temporal lobe in more anxious 
mice are well in accordance with the previous findings obtained on rats. The 
expression of Lsamp 1a transcript showed correlations with more measures of 
anxiety in the elevated plus maze than 1b transcript, probably reflecting its role 
in the shaping of anxiety-related neural circuits in the temporal lobe. Why we 
could not see differences in Lsamp expression in the acute fear test, could partly 
be explained by the findings of Lamprecht et al., 2009, who found that in the 
lateral amygdala, the timing of the elevation of Lsamp expression upon fear-
generating stimulus (footshock) depends on whether the stimulus is paired to a 
conditioned stimulus (tone) or not. Thus, when the footshock was paired with 
the tone, the expression level of Lsamp showed elevation at the 5-h time point, 
and when the footshock was not paired with the tone, Lsamp expression was 
elevated at the 30-minute time point (Lamprecht et al., 2009). In our study 
design, we were not able to detect the elevation of Lsamp expression at our 
chosen time point, but this does not exclude the possibility that the rise in 
Lsamp expression could have occurred later. 
In the social interaction test, significant correlations between the sniffing 
behaviour and the expression level of Lsamp transcripts occurred in the hippo-
campus and ventral striatum, but not in temporal lobe. The expression of Lsamp 
62 
1a transcript in the ventral striatum positively correlated with the sniffing of the 
anogenital area of the other male, which can be considered as an agonistic 
behaviour as it often precedes aggressive attacks (Innos et al., 2011). The 
Lsamp-/- mice show notable decrease in agonistic behaviour manifested by lack 
of whisker trimming and aggressive attacks as well as reduced anogenital 
sniffing between males (Innos et al., 2011). Ventral striatum is involved in 
reward-motivated behaviour, which includes, among others, reward related to 
social defeat of conspecifics (van Erp and Miczek, 2000; Ferrari et al., 2003). 
Therefore, the function of the ventral striatum might be altered in case of Lsamp 
deficiency. 
Sniffing of other body parts negatively correlated with the expression level 
of both Lsamp 1a and 1b transcripts in the hippocampus. Notably, several 
hippocampal functions are affected following the genetic invalidation of Lsamp. 
Lsamp-/- mice display spatial memory deficit, reduction in the CA1 long term 
potentiation, and increased activity in novel environment (Catania et al., 2008; 
Innos et al., 2011; Qiu et al., 2010). Known for its principal role in spatial and 
contextual memory, the function of the hippocampus is also involved in 
anxiety-related and social behaviour (File et al., 2000; Moser and Moser, 1998). 
General social sniffing is not altered in Lsamp-/- mice (Innos et al., 2011; Innos 
et al., 2012); thus, less time spent involved in social sniffing might reflect the 
higher trait anxiety that correlates with the expression of Lsamp transcripts in 
the hippocampus. Less social interaction is a measure of higher anxiety, as 
shown by File and Hyde, 1978, who designed the test to evaluate the effect of 
anxiolytic drugs. Lsamp-/- mice are less anxious in novel and stressful environ-
ments (Catania et al., 2008; Innos et al., 2011; Innos et al., 2012). Both the 
Lsamp knockout studies and the present findings endorse the role of LSAMP in 
various hippocampal functions, including the regulation of anxiety.  
The role of Lsamp in the regulation of behaviour is related to the functioning 
of major neurotransmitter systems in the brain. GABA-ergic, serotonergic and 
dopaminergic transmission is altered in the Lsamp-/- mice (Innos et al., 2011; 
Innos et al, 2013). In the temporal lobe of Lsamp-/- mice, the ratio between the 
transcripts of the α subunit of GABAA receptor genes Gabra2 and Gabra1 is 
shifted in favour of the Gabra2 gene (Innos et al., 2011). This could be a 
possible reason for the reduced anxiety in Lsamp KO mice, since the α2 subunit 
is most relevant in mediating the anxiolytic effect of benzodiazepine drugs 
through the GABAA receptor (Löw et al., 2000; Möhler, 2002). In addition, 
Lsamp KO mice display increased serotonergic tone in the dorsal striatum and 
mesencephalon and lower sensitivity to amphetamine underlined by lower 
expression of dopamine transporter in the midbrain (Innos et al., 2013). The 
elevation in serotonergic transmission could be responsible for the reduced 
aggressiveness and social dominance, as decreased levels of 5-HT are widely 
shown to promote social aggression (Montoya et al., 2012).  
In humans, polymorphisms in the LSAMP gene have been associated with 
predisposition to mood and anxiety disorders (Koido et al., 2012) and 
schizophrenia (Chen et al., 2018; Koido et al., 2014). In post-mortem patients of 
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schizophrenia, the protein level of LSAMP is increased in the dorsolateral 
prefrontal cortex (Behan et al., 2009) and orbitofrontal cortex (Velásquez et al., 
2017), brain regions involved in memory, speech, and cognitive and executive 
functions. In the dorsolateral prefrontal cortex of the schizophrenia patients, 
abnormally high neuronal density has been reported, suggesting neuronal 
atrophy in this brain region (Selemon et al., 1995; Selemon et al., 1998; Sele-
mon et al., 2003). Regarding the role of LSAMP in neural development and 
synaptogenesis, either directly or through the induction of BDNF, it is possible 
that LSAMP might participate in the compensatory mechanisms triggered by 
pathological changes in the neural connectivity of the dorsolateral prefrontal 
cortex of schizophrenia patients. As the two-promoter structure of Lsamp is 
strictly conserved across different species (Pimenta and Levitt, 2004), it is 
probable that the alternatively regulated expression is needed for the integrity of 
the functions performed by LSAMP protein. All the single nucleotide 
polymorphisms shown to associate with increased risk for depression and 
bipolar disorder reside in the first intron (Koido et al., 2012). Furthermore, 
LSAMP polymorphisms causing susceptibility for coronary artery disease also 
reside in the first intron and bring about reduced expression of LSAMP 1a 
transcript (Wang et al., 2008). These lines of evidence and the present study 
suggest for distinct roles of the 1a and 1b transcripts of Lsamp gene in the 
regulation of the development and functioning of neural networks. Further 
studies are needed to gain better understanding of the significance of the two-
promoter structure of Lsamp in the context of subcellular localisation, neurite 
growth, synaptic remodelling, regulation of behaviour and psychiatric disease.  
 
 
6. Table of Lsamp expression 
Table 3. LSAMP protein expression and Lsamp 1a and 1b promoter activity in the 
rodent brain. The principal function of each brain structure is brought out in the right 







1a 1b Principal functions 
Olfactory bulb//mitral cell layer 0 3 1 1 Olfactory 
Cerebral cortex      
Orbital cortex/medial prefrontal 
cortex//prefrontal cortex 
4 3 2 0 Decision-making, 
memory 
Pre- and infralimbic cortex/medial 
prefrontal cortex//Pre- and 
infralimbic cortex 
4 2 3 0 Control of fear 
behaviour 









1a 1b Principal functions 
Cingulate cortex/anterior and 
posterior cingulate cortex//anterior 
and posterior cingulate cortex 
3 and 2 3 and 2 4 0 Emotions, motivation 
Retrosplenial agranular cortex   0 2 Visually guided 
navigation, memory 
Retrosplenial granular cortex   3 1 Navigation, memory 
Granular insular cortex/insular 
cortex//insula 
3 3 3 1 Emotions, autonomic 
control, gustatory 
Agranular insular cortex/insular 
cortex//insula 
3 3 3 0 Emotions, autonomic 
control 
Ectorhinal cortex//perirhinal cortex  2 1 0 Object recognition, 
memory 
Entorhinal cortex 4 2 0 1 Navigation, spatial 
memory 
Claustrum   0 1 Consciousness 
Dorsal endopiriform nucleus   0 2 Olfactory, gustatory 
Piriform cortex 0 3 3 2 Olfactory 
Temporal association cortex   2 1 Object recognition 
Parietal association cortex   1 1 Attention 
Primary auditory cortex/auditory 
cortex//auditory cortex 
0 1 1 2 Auditory 
Secondary auditory cortex/auditory 
cortex//auditory cortex 
0 1 1 2 Auditory 
Primary visual cortex/visual 
cortex//visual cortex 
0 0 0 3 Visual 
Secondary visual cortex/visual 
cortex//visual cortex 








0 1 1 3 Sensory 
Primary motor cortex/sensorimotor 
cortex//sensorimotor cortex 




0 1 1 0 Motor 
Septal and basal forebrain regions      
Medial septal nucleus/septum// 
medial septal nucleus 
4 2 1 0 Generation of theta 








1a 1b Principal functions 
Lateral septal nucleus, dorsal 
part/septum//lateral septal nucleus, 
dorsal part 
4 2 2 3 Social and motivated 
behaviour, stress 
response 
Lateral septal nucleus, ventral 
part/septum//lateral septal nucleus, 
ventral part 
4 2 2 2 Social and motivated 
behaviour, stress 
response 
Lateral septal nucleus, intermediate 
part/septum//lateral septal nucleus, 
intermediate part 
4 1 0 1 Social and motivated 
behaviour, stress 
response 
Septofimbrial nucleus   2 3 Unknown 
Subfornical organ  2 1 2 Osmoregulation, 
cardiovascular 
regulation, feeding 
Bed nucleus of the anterior 
commissure 
  0 4 Fear response 
Lateral bed nucleus of stria 
terminalis/bed nucleus of stria 
terminalis//bed nucleus of stria 
terminalis 
4 2 1 1 Anxiety, motivated 
behaviour 
Medial bed nucleus of stria 
terminalis/bed nucleus of stria 
terminalis//bed nucleus of stria 
terminalis, encapsulated 
4 3 3 1 Anxiety, reproductive 
behaviour, maternal 
behaviour 
Basal ganglia      
Olfactory tubercle 3 3 2 0 Olfactory, motivated 
behaviour 
Nucleus accumbens core/nucleus 
accumbens// nucleus accumbens 
4 2 3 1 Motivated behaviour 
Nucleus accumbens shell/nucleus 
accumbens// nucleus accumbens 
4 2 3 1 Motivated behaviour 
Caudate putamen 2 1 0 1 Motor, motivated 
behaviour 
Globus pallidus  2 0 1 Motor 
Lateral stripe of striatum   0 3 Unknown 
Hippocampal formation      
CA1/hippocampus//CA1 4 3 4 1 Memory, navigation, 
stress 
CA3/hippocampus//CA3 4 4 4 1 Memory, navigation, 
stress 
Dentate gyrus/hippocampus// 
anterodorsal and caudoventral 
dentate gyrus 









1a 1b Principal functions 
Subiculum 4 3 2 0 Memory, navigation, 
stress 
Amygdala      
Amygdalohippocampal area   4 0 Emotions 
Nucleus of the lateral olfactory tract   3 0 Olfactory 
Intercalated nuclei/ amygdala 4  0 1 Fear extinction 
Central nucleus/amygdala// central 
nucleus 
4 2 1 3 Fear response, motivated 
behaviour 
Lateral nucleus/amygdala// lateral 
nucleus 
4 2 3 1 Fear memory 
Basolateral nucleus/ 
amygdala//basolateral nucleus 
4 3 3 0 Fear response and 
memory 
Basomedial nucleus/ amygdala 4  3 0 Anxiety 
Medial nucleus/amygdala// medial 
nucleus 
4 2 3 1 Social and reproductive 








4  4 0 Predator fear 
Posterolateral cortical 
nucleus/amygdala//cortical nucleus 
4 3 3 1 Olfactory 
Posteromedial cortical 
nucleus/amygdala//cortical nucleus 
4 3 4 1 Reproductive behaviour 
Hypothalamus      
Medial preoptic nucleus  3 4 0 Reproductive behaviour 
Medial preoptic area/ preoptic 
area//medial preoptic area 
4 3 2 0 Reproductive and 
parental behaviour, 
thermoregulation 
Lateral preoptic area/ preoptic 
area//lateral preoptic area 
4 2 2 0 Thirst, sleep 
Periventricular hypothalamic 
nucleus 
1 2 0 4 Production of hormones 





 2 0 4 Reproductive behaviour 















 2 2 0 Aggression 
Supraoptic nucleus 3 4 0 2 Osmoregulation, stress 
Suprachiasmatic nucleus  2 0 4 Circadian rhythms 
Paraventricular nucleus/ para-
ventricular nucleus// magnocellular 
and parvocellular regions of the 
paraventricular nucleus 
0 4 and 2 3 4 Energy homeostasis, 
neuroendocrine and 
autonomic functions, 
social and reproductive 
behaviour, stress 
Medial tuberal nucleus   3 0 Aggression 
Dorsomedial hypothalamus, 
compact 
  3 2 Emotional stress 
response, circadian 
rhythms, arousal 




nucleus, anterior part/ ventromedial 
hypothalamic nucleus// 
ventromedial hypothalamic nucleus 
4 3 0 2 Satiety 
Ventromedial hypothalamic 
nucleus, ventrolateral part/ ventro-
medial hypothalamic nucleus// 
ventromedial hypothalamic nucleus 
4 3 3 0 Aggression, reproductive 
behaviour, satiety 
Ventromedial hypothalamic 
nucleus, dorsomedial part/ ventro-
medial hypothalamic nucleus// 
ventromedial hypothalamic nucleus 
4 3 3 0 Fear behaviour 
Arcuate nucleus 0 1 0 4 Regulation of feeding, 
growth and reproduction 
Mammillary bodies/mammillary 
bodies// medial mammillary 
nucleus 
3 2 4 4 Spatial and episodic 
memory 
Ventral tuberomammillary nucleus   2 4 Sleep, arousal, energy 
homeostasis, memory 
Ventromedial preoptic nucleus   3 0 Reproductive behaviour 
Thalamus      
Anterodorsal thalamic nucleus/ 
anterior thalamic nuclei//antero-
dorsal thalamic nucleus 









1a 1b Principal functions 
Anteroventral thalamic nucleus/ 
anterior thalamic nuclei//antero-
ventral thalamic nucleus 
4 1 2 0 Learning, spatial 
memory 
Anteromedial thalamic nucleus/ 
anterior thalamic nuclei//antero-
medial thalamic nucleus 
4 3 1 0 Learning, spatial 
memory 
Paraventricular thalamic nucleus 4 4 2 3 Emotional arousal, 
anxiety, stress 
Ventrolateral thalamic nucleus 0 1 0 1 Motor 
Ventromedial thalamic nucleus  1 0 0 Motor 
Ventral posteromedial thalamic 
nucleus/ ventrobasal complex// 
ventral posteromedial thalamic 
nucleus 
0 2 0 3 Gustatory, 
somatosensory 
Ventral posterolateral thalamic 
nucleus/ ventrobasal complex// 
ventral posterolateral thalamic 
nucleus 
0 2 0 3 Somatosensory 
Parataenial thalamic nucleus  4 1 4 Viscerolimbic 




nucleus//rostral and posterior 
laterodorsal thalamic nucleus 
2 3 and 2 0 2 Spatial learning, 
somatosensory 
processing 
Central medial thalamic nucleus  3 2 0 Cognitive, arousal 
Paracentral thalamic nucleus   1 2 Cognitive, pain 
processing 
Parafascicular thalamic nucleus  2 3 2 Behavioural flexibility, 
pain processing 
Reuniens thalamic nucleus  2 0 1 Spatial navigation, fear 
memory, resilience to 
depressive states 
Reticular thalamic nucleus  3 2 0 Attention, sensory gating 
Xiphoid thalamic nucleus   1 2 Fear 
Interanteromedial thalamic nucleus   0 2 Spatial navigation and 
memory 
Medial habenula/ habenula//medial 
habenula 
2 3 4 4 Anxiety, spatial 
memory, inhibitory 
control of behaviour 
Lateral habenula/habenula// lateral 
habenula, medial and lateral part 
2 2 and 1 0 2 Negative reward 
prediction 








1a 1b Principal functions 
Lateral posterior thalamic nucleus  1 0 2 Visual, sensory 
association 
Dorsal lateral geniculate nucleus/ 
lateral geniculate nucleus//dorsal 
lateral geniculate nucleus 
0 2 0 4 Visual 
Ventral lateral geniculate nucleus/ 
lateral geniculate nucleus//ventral 
lateral geniculate nucleus 
0 0 0 1 Visual, circadian rhythm 
Medial geniculate nucleus 0 2 0 3 Auditory 
Subthalamic nucleus  2 1 2 Control of movements, 
impulse control, 
cognition 
Zona incerta  0 0 0 Viscerolimbic, pain 
processing, sensory 
gating 
Brainstem      
Superior colliculus 4 2 0 2 Visual 
Inferior colliculus, central nucleus/ 
inferior colliculus// inferior 
colliculus 
0 2 0 3 Auditory 
Substantia nigra, pars reticulata/ 
substantia nigra// substantia nigra, 
pars reticulata 
3 1 1 2 Motor control, 
motivation 
Substantia nigra, pars compacta/ 
substantia nigra// substantia nigra, 
pars compacta 
3 2 1 2 Motor control and 
learning, regulation of 
sleep 
Ventral tegmental area 3 2   Motivation, cognition, 
learning 
Interpeduncular nucleus  2   Aversive states 
Periaqueductal grey  2 1 1 Modulation of pain, fear 
behaviour, maternal 
behaviour 
Mesencephalic raphe nuclei//dorsal 
raphe 
2 2   Memory, reward-related 
behaviour, sleep-wake 
cycle 
Red nucleus 0 1   Motor 
III cranial nerve nucleus//oculo-
motor nucleus 
0 2   Motor 
IV cranial nerve nucleus//trochlear 
nucleus 
0 2   Motor 
Dorsal tegmental nucleus 3 3   Arousal 









1a 1b Principal functions 
Reticular formation//lateral reticular 
nucleus 
2 3   Arousal, consciousness, 
motor and visceral 
control 
Nuclei of the lateral lemniscus  2 0 3 Auditory 
Solitary nucleus 4 2 0 1 Multisensory 
Superior olivary complex  2 0 1 Auditory 
Nucleus of the trapezoid body  3 0 2 Auditory 
Dorsal cochlear nucleus/ cochlear 
nuclei//dorsal cochlear nucleus 
0 1 0 3 Auditory 
Ventral cochlear nucleus/ cochlear 
nuclei//ventral cochlear nucleus 
0 3 0 3 Auditory 
Cuneate nucleus   0 2 Somatosensory 
Gracile nucleus   0 2 Somatosensory 
Spinal trigeminal nucleus/V cranial 
nerve nucleus// spinal trigeminal 
nucleus 
0 2 0 2 Somatosensory 
V cranial nerve nucleus//principal 
sensory trigeminal nucleus 
0 2   Somatosensory 
V cranial nerve nucleus//motor 
trigeminal nucleus 
0 2   Motor 
VI cranial nerve nucleus// abducens 
nucleus 
0 2   Motor 
VII cranial nerve nucleus// facial 
nucleus 
0 3   Motor 
VIII cranial nerve nucleus// 
superior, medial and lateral 
vestibular nucleus 
0 1, 2, 1   Sensory 
XII cranial nerve nucleus// hypo-
glossal nucleus 
0 2   Motor 
Pontine and medullary raphe 
nuclei//nucleus raphe magnus 
0 2   Breathing, digestion, 
regulation of cardiac 
function, modulation of 
pain 
Locus coeruleus 2 3   Stress response, arousal, 
sleep, memory, emotions 
Parabrachial nucleus 4    Gustatory, feeding, 
breathing, arousal, 
thermoregulation 
Nucleus ambiguus  2   Somatomotor, 
visceromotor 








1a 1b Principal functions 
Cerebellum     Motor control, pain 
processing, learning, 
memory, emotions 
Molecular layer 1 1 0 1 Inhibitory control of 
Purkinje cells 
Granule cell layer 0 0 1 0 Processing of cerebral 
input, excitatory input to 
Purkinje cells and 
molecular layer 
Purkinje cell layer 0 2 0 3 Inhibitory control of 
cerebellar output 
Deep cerebellar nuclei// dentate 
nucleus 
0 2   Cerebellar output, motor, 
cognitive, visuospatial 
Deep cerebellar nuclei// interpositus 
nucleus 
0 1   Cerebellar output, motor 
Deep cerebellar nuclei// fastigial 
nucleus 
0 0   Cerebellar output, motor 
Spinal cord      
Dorsal horn/lamina II 3  2 2 Relaying somatosensory 
information from the 
body 
Ventral horn/all other laminae 0  2 2 Motor 
Intermediolateral cell column 2    Parasympathetic 
innervation of the body 
 
 
Lsamp 1a promoter activity is studied by radioactive and non-radioactive RNA 
in situ hybridization, Lsamp 1b promoter activity is studied by radioactive RNA 
in situ hybridization and X-gal staining X-gal staining of Lsamp-β-galactosidase 
knockin mouse brains. Categories of the estimation of staining intensity: 0 – not 
detectable; 1 – barely detectable, 2 – low, 3 – moderate, 4 – high. The brain 
regions are named as follows: name according to Ref III (after Franklin and 




SUGGESTIONS FOR FURTHER STUDIES 
The development of the emotional brain begins during the embryonic stage and 
continues postnatally for an extended period and is adjusted by the crosstalk 
between the genes and environment. Predisposition to psychopathologies, such 
as mood and anxiety disorders and psychotic conditions is often genetically 
based, but the outbreak of the disease depends on environmental factors. There-
fore, it is important to understand the genetic determinants of the development 
and how they interact with the intrinsic milieu of the organism and external 
environment. The results of the experiments included in this thesis have 
widened the knowledge of the function of WFS1 and LSAMP in the context of 
development and behavioural regulation, but also raised new questions and 
pointed towards further research directions. 
In case of WFS1, it is essential to understand how the dysfunction of the 
protein leads to defects in myelination and how the developmental shortcoming 
is related to neurodegeneration widely reported in older WS patients. As several 
lines of evidence indicate a link between WFS1 and other proteins implicated in 
neurodevelopmental processes (Fonseca et al., 2010; Guo et al., 2011; Kawada 
et al., 2014; Shrestha et al., 2015), the mechanisms how WFS1 affects the 
developmental events through direct or indirect interaction with these proteins 
(namely, WNT7A, NTF3 and E3 ubiquitin ligases SMURF1 and HRD1) require 
further investigation.  
The disturbances in the dopaminergic and serotonergic systems in case of the 
lack of functional WFS1 need further study. Specifically, the relation between 
WFS1 and the intracellular pathway of D1-type dopamine receptors requires 
investigating. The possible involvement of WFS1 in regulating the adenylyl 
cyclase activity, which is an intracellular effect of D1 receptor binding, is of 
particular interest. Also, the relation between WFS1 and D2-type dopamine 
receptors needs to be addressed.  
In addition, it would be essential to verify in which cell types Wfs1 is 
expressed and to study the connectivity between Wfs1-expressing cells to better 
understand the function of WFS1 on the circuit level. Here, the intercalated 
amygdala, being involved in the feedforward inhibition of the central amygdala 
activity and expression of fear extinction (Ehrlich et al., 2009; Likhtik et al., 
2008), provides an interesting site for dissecting the function of WFS1 in the 
amygdala fear circuits. In conjunction with this, the role of WFS1 in the 
GABAergic system should be elaborated in further detail. 
From the evolutionary perspective, studying the expression of Wfs1 in the 
amphibian brain could give more information on the ancestral state of pallial 
and subpallial distribution of WFS1 and help to resolve the question of common 
developmental origin of the Wfs1 expression pattern in the pallial amygdala. 
Also, an interesting topic that might shed light to the molecular function of 
WFS1 would be the expression of Wfs1 in a non-hypoxia resistant chelonian 
species. 
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An interesting feature of the developmental expression of both Lsamp and 
Wfs1 was their largely transient mRNA expression in the dorsal striatum. The 
role of such extensive developmental expression of both is unknown and further 
studies could provide important knowledge regarding the formation of neural 
circuits important for motivation, emotion and executive functioning. 
In case of Lsamp, further studies are needed to understand the importance of 
the conserved dual promoter structure. It is essential to map the activity of the 
two alternative promoters in the developmental stages parting E15.5 and adult-
hood. The differential pattern of Lsamp 1a and 1b promoter activity in com-
parison with the protein expression points to two important aspects that need 
further study. First, the intracellular localization of the protein synthesized from 
each transcript should be thoroughly investigated. Secondly, the mechanisms 
how Lsamp 1a and 1b transcripts contribute to the formation of distinct neural 
circuits need to be elucidated. 
The underlying mechanisms and causal relations between the Lsamp tran-
scriptsʼ expressions and measures of anxiety and social behaviour should be 
clarified. Also, measuring the level of LSAMP protein in different brain regions 
in relation to behavioural characteristics could add to the knowledge of the role 
of Lsamp in behaviour and psychiatric disease. In wider context, the regulatory 
mechanisms determining the expressional activity of Lsamp gene and in-
fluencing the translational activity, functionality and stability of LSAMP pro-






The overall objective of the research presented in this dissertation was to bring 
us closer to understanding how WFS1 and LSAMP, two genes implicated in fear 
and anxiety regulation and susceptibility to psychiatric diseases, are related the 
neurodevelopmental aspects of behaviour. The age of onset of common neuro-
psychiatric diseases, such as depression, bipolar disorder, anxiety disorders, and 
schizophrenia falls into late childhood to early adulthood, suggesting a develop-
mental aetiology. Since both WFS1 and LSAMP have been associated with 
psychiatric diseases, understanding their role in brain development can lead us 
closer to comprehending the causes of psychiatric diseases and elaborating 
better treatment. Both Wfs1 and Lsamp are expressed in the embryonic brain, 
and the expression of both undergoes developmental changes which suggests a 
specific role during development. The knowledge obtained from the experi-
ments included into this thesis helps to better understand the roles of Wfs1 and 
Lsamp in the formation and functioning of different brain structures and points 
at possible directions for succeeding studies.  
The main results are summarized as follows: 
1.  The expression of Wfs1 is initiated at around E15.5 in the mouse brain. The 
initiation of Wfs1 expression falls into the time window of the beginning of 
synaptic activity after the end of the peak of the neuronal migration. The 
expression of Wfs1 is initiated in numerous regions of the brain and roughly 
follows the maturation of synaptic functionality. The first expression regions 
of Wfs1 are the dorsal striatum and the amygdala; by the time of birth, the 
expression is widespread in all striatal and amygdaloid regions and dience-
phalon and emerging in the cortical structures, including neocortical and 
olfactory areas and hippocampus. After postnatal day 2, the widespread 
expression of Wfs1 becomes gradually downregulated, achieving its relati-
vely restricted adult pattern (mainly ventral striatum, caudal CPu, central 
extended amygdala, piriform cortex, layer II/III of the neocortex and sulcal 
cortical areas, CA1 region of the hippocampus, reticular thalamic nucleus) 
after puberty. Our findings extend the previous results that describe the 
expression of Wfs1 in the postnatal and adult mouse brain. 
2.  During embryonic and early postnatal development, the dynamics of Wfs1 
expression shows opposing regulation compared to the markers of develop-
mental endoplasmic reticulum stress. During the perinatal period, the expres-
sion of Wfs1 is upregulated in a wide range of brain structures, whereas the 
expression of endoplasmic stress markers Grp78, Grp94 and CHOP shows 
gradual downregulation. The expression levels do not differ between wt and 
Wfs1-/- pups. These results indicate that the transient widespread expression 
of Wfs1 in the perinatal brain is not involved in the regulation of the 
developmental ER stress. 
3.  Across different evolutionary lineages, the expression of Wfs1 is conserved 
in the striatal and subpallial amygdaloid structures and lacking in the pallidal 
regions. In pallial regions, the expression of Wfs1 shows considerable 
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variation between the studied species: house mouse, domestic chick and red-
eared slider turtle. The expression of Wfs1 lacks in the hyperpallium of the 
avian brain, while being present in the neocortex of the mouse and dorsal 
cortex of the turtle. This suggests independent gain in the dorsal pallial deri-
vatives in the mammalian and chelonian lineages or loss in the avian lineage. 
The presence of Wfs1 expression in the hippocampal homologue and pallial 
amygdaloid structures of all lineages favours the hypothesis of common 
ancestral pattern. 
4.  Our expression analysis in the brain of mouse, domestic chick and red-eared 
slider turtle indicates that the relation between Wfs1 and D1-type dopamine 
receptors is evolutionarily conserved. Across different evolutionary lineages, 
the expression of Wfs1 shows considerable overlapping with the expression 
of Drd1a, the gene encoding the most widespread D1-type dopamine 
receptor. In the hippocampus of Wfs1-/- mice, the ligand binding of D1-type 
dopamine receptors is increased. This result adds further evidence to the 
previous findings pointing to the altered dopaminergic system in Wfs1-/- mice 
and shows the specific involvement of D1-type dopamine receptors. 
5.  The two alternative promoters of the Lsamp gene show rather comple-
mentary patterns of activity in the mouse brain. While Lsamp 1a transcript is 
predominantly restricted to the limbic regions (e.g. hippocampus, amygdala, 
limbic-associated cortices, anterior thalamus, limbic-related hypothalamic 
regions), Lsamp 1b promoter shows strong activity in the sensory and motor 
pathways (visual, somatosensory and auditory pathways). The olfactory and 
gustatory pathways, which are largely integrated with the emotion-pro-
cessing functions, show activity of both Lsamp 1a and 1b promoters. A 
higher expression of Lsamp 1a transcript in the temporal lobe correlates with 
higher trait anxiety in mice. A lower level of Lsamp 1a and 1b transcripts in 
the hippocampus correlates with a prolonged time of engagement in social 
sniffing between unfamiliar mice. Higher level of Lsamp 1a transcript in the 
ventral striatum positively correlates with the time involved in anogenital 
sniffing. As Lsamp 1a was predominantly expressed in the brain regions 
belonging to the emotion-processing circuits, the higher expression level 
indicating higher anxiety reveals its relevance for anxiety-related behaviou-
ral control. Correlations between the expression level of Lsamp gene tran-
scripts and measures of social behaviour underline previous findings 
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SUMMARY IN ESTONIAN 
Arenguline lähenemine emotsionaalse käitumisega seotud 
geenide Wfs1 ja Lsampʼi funktsiooni uurimisel 
Psühhiaatriliste haiguste algpõhjused peituvad sageli aju arengus. Arenev aju on 
väga plastiline ning vastuvõtlik välistele mõjuteguritele. Inimesel kestab aju 
areng eriliselt kaua: veel pärast sündi jätkub intensiivne neurogenees, millega 
kaasneb massiline sünapside teke ja samal ajal kasutusest välja jäävate sünap-
side kustutamine. Sünaptilise võrgustiku ülesehitamine kestab kuni varase täis-
kasvanueani ning palju väiksemas skaalas jätkub selle ümberkorraldamine ka 
pärast täiskasvanuks saamist. Seetõttu on inimaju areng seda mõjutavatele tegu-
ritele tundlik väga pika aja kestel. Tundmuste, mõtlemise ja mäluga seotud aju-
piirkondade areng sõltub keskkonnast pärinevast sisendist ning nende funkt-
siooni peenhäälestamine võtab seetõttu eriti kaua aega. Keskkonnast ajusse 
jõudvad signaalid mõjutavad paljude aju funktsioneerimises oluliste geenide 
transkriptsioonilise aktiivsuse paikasättimist ning sünaptiliste ühenduste kujune-
mist. Kuna need protsessid on keerulised ja haavatavad, esineb ka palju haigusi, 
mis on seotud aju emotsionaalse arengu häiretega, nagu depression, bipolaarne 
häire, ärevus- ja sõltuvushäired, skisofreenia. 
Käesolevas doktoritöös on kasutatud hiire mudeleid, et uurida emotsionaalse 
käitumise regulatsioonis oluliste geenide Wfs1 ja Lsamp`i rolli aju arengus. Siin 
käsitletud uuringute kaugemad tagamaad ulatuvad 2000-ndate aastate alguses 
Tartu Ülikooli Füsioloogia Instituudis tehtud katseteni, kus lasti rottidel nuu-
sutada kassilõhnaga riidelappi ning selle järel mõõdeti geenide ekspressiooni-
taset amügdalas, mis on hirmukäitumise eest vastutav aju osa. Wfs1 ja Lsamp 
olid nende geenide hulgas, mille puhul täheldati ekspressioonitaseme tõusu 
pärast kassilõhnaga riidelapi nuusutamist.  
Wfs1 e Wolframi sündroom 1 on seotud sündroomiga, mille patsientidel esi-
nevad diabetes insipidus, diabetes mellitus, sensorineuraalne kurtus ja nägemis-
närvi kärbumine. Sageli kaasnevad Wolframi sündroomiga psühhiaatrilised häi-
red ning ühe mittefunktsionaalse Wfs1 alleeli kandjatel on kõrgendatud risk 
vaimuhaigusteks. Lsamp (Limbic system associated membrane protein e limbi-
lise süsteemiga seotud membraanvalku kodeeriv geen) geeni poolt kodeeritava 
valgu funktsioon on seotud emotsionaalses käitumises oluliste ajuosade vahe-
liste ühenduste ülesehitamisega. Lsamp osaleb neuriitide väljakasvu, aksonite 
sihtmärgini jõudmise ja sünaptogeneesi regulatsioonis. Wfs1 funktsiooni on 
rohkem uuritud pankreases ning selle roll närvisüsteemi arengus vajab veel 
selgitamist. Wolframi sündroomi patsientidel on täheldatud teatud aju osade 
puudulikku arengut ja kõrvalekaldeid aju müeliniseerumises juba väga noores 
eas. Nii Wfs1 kui ka Lsamp geeni variandid on seotud meeleolu- ja ärevus-
häirete, skisofreenia ja suitsidaalsusega.  
Kuna aju areng mängib psüühikahäirete kujunemisel väga suurt rolli, on 
käesoleva töö põhieesmärk selgitada, millistes aju arengu etappides on Wfs1 ja 
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Lsamp`i avaldumine vajalik ning mis funktsioone need geenid arenevas ja 
täiskasvanud ajus täidavad.  
Kõigepealt oli eesmärgiks selgitada, millises funktsionaalse küpsemise faasis 
hakatakse erinevates aju piirkondades Wfs1 ekspresseerima. Kuna üks Wfs1 
valgu funktsioon on endoplasmaatilise retiikulumi stressi (ER stressi) vastuse 
regulatsioon, võtsime sihiks selgitada, kas Wfs1 mängib rolli arengu käigus 
tekkiva ER stressi vastuse kontrollis. Kasutades RNA in situ hübridisatsiooni 
metoodikat, näitasime, et Wfs1 hakatakse hiire ajus ekspresseerima pärast 
sünaptilise aktiivsuse algust alates vanusest 15,5 embrüonaalset päeva (E15,5) 
ning Wfs1 ekspressiooni algus järgib ajupiirkondade sünaptilist küpsemist. Esi-
mesed ekspressioonipiirkonnad on dorsaalne striatum ja amügdala. Wfs1 
ekspressioon on kõige ulatuslikum vahemikus sünnist kuni teise postnataalse 
päevani (P2), hõlmates dorsaalse ja ventraalse striatumi, amügdala erinevad 
tuumad, areneva ajukoore ja hipokampuse ning vaheaju. Edasise arengu käigus 
toimub paljudes ajupiirkondades ekspressiooni vähenemine ja kadumine, samas 
kui üksikud struktuurid, nagu hipokampuse CA1 piirkond, ajukoore II/III kiht, 
olfaktoorne koor, kaudaalne dorsaalne striatum, tsentraalne amügdala ja vent-
raalne striatum, hakkavad tugevamini Wfs1 ekspresseerima. Kasutades in situ 
hübridisatsiooni ja reaalaja kvantitatiivset polümeraasi ahelreaktsiooni (PCR-i), 
näitasime, et ER stressi markeerivate geenide Grp78 ja Grp94 tase on embrüo-
naalses ajus kõrge ja reguleeritakse alla ajaks, mil Wfs1 ekspressioon on kõige 
madalam. Nende geenide ekspressioonitaseme mõõtmine metsiktüüpi ja Wfs1 
geeni puudulikkusega hiirtes näitas, et Wfs1 ei osale nende ekspressiooni regu-
latsioonis sünnieelses ja varases sünnijärgses eas. 
Arvestades, et varem on leitud seos Wfs1 ja aju dopamiinergilise süsteemi 
toimimise vahel, otsustasime seda seost põhjalikumalt selgitada, uurides Wfs1 
mõju D1-tüüpi dopamiini retseptorite funktsioneerimisele. Mõõtes radioaktiiv-
selt märgistatud ligandi sidumist, leidsime, et Wfs1 geeni puudulikkusega hiirtes 
on D1-tüüpi dopamiini retseptori sidumiskohti rohkem kui metsiktüüpi hiirtes. 
Et anda Wfs1 ja D1-tüüpi retseptorite seosele laiem evolutsiooniline mõõde, 
uurisime Wfs1 ja levinuima D1-tüüpi retseptori Drd1a ekspressiooni võrdlevalt 
hiire, kodukana ja punakõrv-ilukilpkonna ajus, kasutades RNA in situ hübridi-
satsiooni ja immunohistokeemilist valgu tuvastamist. Nii kana kui kilpkonna 
ajus kattusid Wfs1 ja Drd1a ekspressioonipiirkonnad omavahel peaaegu täieli-
kult. Hiire ajus polnud D1-tüüpi retseptorite Drd1a ja Drd5 ekspressioon Wfs1 
ekspressioonile mRNA tasemel väga sarnane, kuid valgu tasemel oli kattuvus 
märkimisväärne, eriti Drd1 ja Wfs1 vahel. Erinevates fülogeneesiharudes oli 
Wfs1 ekspressioon konserveerunud aju basaalosa päritolu striataalsetes ja amüg-
dala piirkondades ning varieerus aju mantliosa päritolu piirkondades. 
Lsamp`i uurimuses oli eemärgiks kirjeldada selle geeni kahe alternatiivse 
promootori aktiivsuse mustrit arenevas ja täiskasvanud hiire ajus ning uurida 
nendelt promootoritelt sünteesitud alternatiivsete transkriptide rolli sotsiaalses 
ja ärevusega seotud käitumises. Lsamp geenil on kaks evolutsiooniliselt konser-
veerunud alternatiivset esimest eksonit koos eraldi promootoritega. Kuigi nen-
delt promootoritelt sünteesitud mRNAd on 5´-osas erinevad, on küpse valgu 
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järjestus sama, ning alternatiivsete traskriptide roll on selgusetu. Kasutades 
radioaktiivset ja mitteradioaktiivset RNA in situ hübridisatsiooni ning X-gal 
värvingut Lsamp-β-galaktosidaas knockin hiirtel, leidsime, et 1a promootor on 
aktiivne klassikalistes limbilistes struktuurides (hipokampus, amügdala, aju-
koore ja hüpotalamuse limbilised piirkonnad, eesmine talamus). Samas piiritleb 
1b promootori aktiivsus aju sensoorseid juhteteesid ning prevaleerib sensoor-
setes ning motoorsetes ajukoore ja talamuse osades. Käitumiskatsetes ilmnes, et 
kõrgem 1a transkripti ekspressioonitase temporaalsagaras korreleerus suurema 
loomuomase ärevusega ning nii 1a kui 1b transkripti madalam tase hipokam-
puses oli korrelatsioonis kestvama teise hiire nuusutamisega ehk kõrgema 
sotsiaalsusega. Kõrgem 1a transkripti tase ventraalses striatumis oli korrelat-
sioonis teise hiire anogenitaalpiirkonna nuusutamisega, mis on hiirte seas keh-
testav käitumine. Läbi viidud käitumiskatsed toetavad varasemaid uuringuid, 
mille käigus on leitud, et Lsamp geeni puudulikkusega hiirtel esineb vähem 
agressiivset käitumist ning nad on ükskõiksemad ärevust tekitavate olukordade 
suhtes. 
Keskmine vanus, mil haigestutakse psühhiaatrilistesse haigustesse, nagu 
depressioon, bipolaarne häire, ärevushäired ja skisofreenia, langeb erinevate 
haiguste lõikes hilisesse lapsepõlve või varasesse täiskasvanuikka, mis viitab 
tugevale arengulisele komponendile nende haiguste olemuses. Geneetilise eel-
soodumusega haiguse vallandumise võivad määrata traumaatilised emotsio-
naalsed läbielamised või stressirohked eluperioodid. Selle tõttu on oluline 
uurida, kuidas emotsionaalse käitumise regulatsiooniga seotud geenid nagu 
Wfs1 ja Lsamp osalevad aju arengus ning kuidas nad interakteeruvad kesk-
konnast pärinevate ja organismi sisekeskkonna signaalidega. Käesoleva doktori-
töö valmimise käigus saadud uued teadmised aitavad paremini mõista Wfs1 ja 
Lsamp`i rolli erinevate ajupiirkondade arengus ja funktsioneerimises ning 
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